| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF21B ABCC4 MCM4 MCM5 ABCB1 ATP8A1 ATAD2B KIF14 KIF5C HSPA6 ABCB5 SMC6 KIF16B FBH1 RUVBL1 CHD5 ABCB11 MACF1 | 9.18e-07 | 441 | 208 | 18 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF21B ABCC4 MCM4 MCM5 ABCB1 BPTF ATP8A1 ATAD2B KIF14 KIF5C HSPA6 ABCB5 SMC6 KIF16B FBH1 RUVBL1 CHD5 MYO1F ABCB11 MACF1 | 7.05e-06 | 614 | 208 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | modification-dependent protein binding | UIMC1 TNIP1 DAXX BPTF ATAD2B ZCWPW1 ANK2 BAZ2A CHD5 OTUD7A SHARPIN | 1.11e-05 | 206 | 208 | 11 | GO:0140030 |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 1.43e-05 | 15 | 208 | 4 | GO:0008559 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 4.86e-05 | 20 | 208 | 4 | GO:0061665 | |
| GeneOntologyMolecularFunction | IMP dehydrogenase activity | 1.08e-04 | 2 | 208 | 2 | GO:0003938 | |
| GeneOntologyMolecularFunction | GTPase binding | RGPD4 SPTBN1 RGPD1 ITPKA PEX5 IQGAP3 IPO5 RGPD2 RANBP2 TBC1D30 KIF16B PPP6R1 PRKCH | 1.09e-04 | 360 | 208 | 13 | GO:0051020 |
| GeneOntologyMolecularFunction | transcription factor binding | UIMC1 SP1 SP3 ERCC4 DAXX KDM5D FOXA2 TRIP12 BPTF ZNF703 WWP2 APBB2 MED1 RUVBL1 PSIP1 BAZ2A ARID2 CD34 NFAT5 PCNA | 1.24e-04 | 753 | 208 | 20 | GO:0008134 |
| GeneOntologyMolecularFunction | small GTPase binding | RGPD4 RGPD1 ITPKA PEX5 IQGAP3 IPO5 RGPD2 RANBP2 TBC1D30 KIF16B PPP6R1 PRKCH | 1.45e-04 | 321 | 208 | 12 | GO:0031267 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | PRTG SPTBN1 ITGA6 CDH23 FASN NRXN1 CGN NPNT CAMLG THBS1 RUVBL1 TENM3 EPHA2 TLN1 MACF1 ATIC PALLD | 1.88e-04 | 599 | 208 | 17 | GO:0050839 |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 4.15e-04 | 34 | 208 | 4 | GO:0042910 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF21B ABCC4 MCM4 MCM5 SEPTIN6 ABCB1 ATP8A1 ATAD2B KIF14 KIF5C HSPA6 ABCB5 SMC6 KIF16B FBH1 RUVBL1 CHD5 ABCB11 MACF1 | 4.99e-04 | 775 | 208 | 19 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KIF21B ABCC4 MCM4 MCM5 SEPTIN6 ABCB1 ATP8A1 ATAD2B KIF14 KIF5C HSPA6 PRUNE2 ABCB5 SMC6 KIF16B FBH1 RUVBL1 CHD5 ABCB11 MACF1 | 5.06e-04 | 839 | 208 | 20 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KIF21B ABCC4 MCM4 MCM5 SEPTIN6 ABCB1 ATP8A1 ATAD2B KIF14 KIF5C HSPA6 PRUNE2 ABCB5 SMC6 KIF16B FBH1 RUVBL1 CHD5 ABCB11 MACF1 | 5.14e-04 | 840 | 208 | 20 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KIF21B ABCC4 MCM4 MCM5 SEPTIN6 ABCB1 ATP8A1 ATAD2B KIF14 KIF5C HSPA6 PRUNE2 ABCB5 SMC6 KIF16B FBH1 RUVBL1 CHD5 ABCB11 MACF1 | 5.14e-04 | 840 | 208 | 20 | GO:0016818 |
| GeneOntologyMolecularFunction | SUMO transferase activity | 5.19e-04 | 36 | 208 | 4 | GO:0019789 | |
| GeneOntologyMolecularFunction | efflux transmembrane transporter activity | 5.64e-04 | 16 | 208 | 3 | GO:0015562 | |
| GeneOntologyMolecularFunction | 3'-5' DNA helicase activity | 5.64e-04 | 16 | 208 | 3 | GO:0043138 | |
| GeneOntologyMolecularFunction | ABC-type bile acid transporter activity | 6.39e-04 | 4 | 208 | 2 | GO:0015432 | |
| GeneOntologyMolecularFunction | ATPase-coupled organic acid transmembrane transporter activity | 6.39e-04 | 4 | 208 | 2 | GO:0033283 | |
| GeneOntologyMolecularFunction | ATPase-coupled monocarboxylic acid transmembrane transporter activity | 6.39e-04 | 4 | 208 | 2 | GO:0033285 | |
| GeneOntologyMolecularFunction | ATPase-coupled carboxylic acid transmembrane transporter activity | 6.39e-04 | 4 | 208 | 2 | GO:0033284 | |
| GeneOntologyMolecularFunction | plus-end-directed microtubule motor activity | 6.80e-04 | 17 | 208 | 3 | GO:0008574 | |
| GeneOntologyMolecularFunction | collagen V binding | 1.06e-03 | 5 | 208 | 2 | GO:0070052 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.49e-03 | 118 | 208 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.68e-03 | 49 | 208 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 1.81e-03 | 50 | 208 | 4 | GO:0003755 | |
| GeneOntologyMolecularFunction | histone binding | 1.90e-03 | 265 | 208 | 9 | GO:0042393 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 2.16e-03 | 127 | 208 | 6 | GO:0016616 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.16e-03 | 127 | 208 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 2.25e-03 | 53 | 208 | 4 | GO:0016859 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 1.23e-07 | 13 | 209 | 5 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.89e-07 | 14 | 209 | 5 | GO:1903299 | |
| GeneOntologyBiologicalProcess | XMP metabolic process | 6.95e-07 | 8 | 209 | 4 | GO:0097292 | |
| GeneOntologyBiologicalProcess | 'de novo' XMP biosynthetic process | 6.95e-07 | 8 | 209 | 4 | GO:0097294 | |
| GeneOntologyBiologicalProcess | XMP biosynthetic process | 6.95e-07 | 8 | 209 | 4 | GO:0097293 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 1.24e-06 | 9 | 209 | 4 | GO:0033133 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.39e-06 | 20 | 209 | 5 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 2.05e-06 | 10 | 209 | 4 | GO:1903301 | |
| GeneOntologyBiologicalProcess | GMP biosynthetic process | 1.69e-05 | 16 | 209 | 4 | GO:0006177 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to cell periphery | 1.98e-05 | 82 | 209 | 7 | GO:1904377 | |
| GeneOntologyBiologicalProcess | RNA localization | RGPD4 RGPD1 NXF2 KIF5C FUBP3 RGPD2 RANBP2 CPSF6 POM121L2 RUVBL1 | 7.72e-05 | 217 | 209 | 10 | GO:0006403 |
| GeneOntologyBiologicalProcess | purine ribonucleoside monophosphate biosynthetic process | 7.80e-05 | 23 | 209 | 4 | GO:0009168 | |
| GeneOntologyBiologicalProcess | purine nucleoside monophosphate biosynthetic process | 1.10e-04 | 25 | 209 | 4 | GO:0009127 | |
| GeneOntologyBiologicalProcess | chromatin organization | UIMC1 DAXX KDM5D FOXA2 TRIP12 ZNF518A BPTF ATAD2B MKI67 TET3 SMC6 TBL1XR1 PHC1 RNF2 RUVBL1 PSIP1 ZNF827 BAZ2A ARID2 CHD5 BICRAL NFAT5 | 1.19e-04 | 896 | 209 | 22 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein kinase A signaling | 1.22e-04 | 48 | 209 | 5 | GO:0010737 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | UIMC1 DAXX KDM5D FOXA2 TRIP12 ZNF518A BPTF ATAD2B MKI67 TET3 SMC6 MED1 TBL1XR1 PHC1 RNF2 RUVBL1 PSIP1 ZNF827 BAZ2A ARID2 CHD5 BICRAL NFAT5 | 2.12e-04 | 999 | 209 | 23 | GO:0071824 |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 6.46e-07 | 8 | 208 | 4 | GO:1990723 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.66e-06 | 21 | 208 | 5 | GO:0106068 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.91e-06 | 10 | 208 | 4 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 8.82e-06 | 14 | 208 | 4 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RGPD4 UIMC1 MIS18BP1 ERCC4 RGPD1 E2F7 MCM4 MCM5 BPTF NFKB1 NXF2 BOD1L1 HSPA6 IPO5 RGPD2 RANBP2 CPSF6 SUN1 POM121L2 POU2F1 MED1 TBL1XR1 PHC1 RNF2 RUVBL1 BAZ2A ARID2 CHD5 BICRAL CDC27 PCNA | 1.67e-05 | 1377 | 208 | 31 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 2.61e-05 | 18 | 208 | 4 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 4.07e-05 | 20 | 208 | 4 | GO:0042405 | |
| GeneOntologyCellularComponent | sex chromosome | 7.36e-05 | 44 | 208 | 5 | GO:0000803 | |
| GeneOntologyCellularComponent | MCM complex | 1.51e-04 | 11 | 208 | 3 | GO:0042555 | |
| GeneOntologyCellularComponent | chromosomal region | MIS18BP1 ERCC4 MCM4 MCM5 DAXX SEPTIN6 AURKC MKI67 SUN1 SMC6 ZNF827 ARID2 PCNA | 3.22e-04 | 421 | 208 | 13 | GO:0098687 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 3.98e-04 | 96 | 208 | 6 | GO:0070603 | |
| GeneOntologyCellularComponent | nuclear pore | 5.22e-04 | 101 | 208 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | heterochromatin | 5.22e-04 | 101 | 208 | 6 | GO:0000792 | |
| GeneOntologyCellularComponent | interchromatin granule | 9.66e-04 | 5 | 208 | 2 | GO:0035061 | |
| GeneOntologyCellularComponent | axonal growth cone | 1.03e-03 | 45 | 208 | 4 | GO:0044295 | |
| GeneOntologyCellularComponent | kinesin complex | 1.42e-03 | 49 | 208 | 4 | GO:0005871 | |
| GeneOntologyCellularComponent | external side of apical plasma membrane | 1.44e-03 | 6 | 208 | 2 | GO:0098591 | |
| MousePheno | increased hepatocellular carcinoma incidence | 1.95e-05 | 70 | 167 | 7 | MP:0003331 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 3.20e-05 | 16 | 167 | 4 | MP:0003701 | |
| Domain | Ran_BP1 | 6.51e-06 | 12 | 205 | 4 | PF00638 | |
| Domain | RANBD1 | 6.51e-06 | 12 | 205 | 4 | PS50196 | |
| Domain | RanBD | 9.33e-06 | 13 | 205 | 4 | SM00160 | |
| Domain | Ran_bind_dom | 9.33e-06 | 13 | 205 | 4 | IPR000156 | |
| Domain | FHA | 1.21e-05 | 28 | 205 | 5 | SM00240 | |
| Domain | TPR | 1.28e-05 | 129 | 205 | 9 | SM00028 | |
| Domain | TPR_repeat | 1.63e-05 | 133 | 205 | 9 | IPR019734 | |
| Domain | FHA_DOMAIN | 2.04e-05 | 31 | 205 | 5 | PS50006 | |
| Domain | FHA | 2.04e-05 | 31 | 205 | 5 | PF00498 | |
| Domain | TPR-contain_dom | 4.24e-05 | 150 | 205 | 9 | IPR013026 | |
| Domain | - | 4.34e-05 | 36 | 205 | 5 | 2.60.200.20 | |
| Domain | FHA_dom | 4.34e-05 | 36 | 205 | 5 | IPR000253 | |
| Domain | Rab_bind | 4.42e-05 | 7 | 205 | 3 | PF16704 | |
| Domain | GCC2_Rab_bind | 4.42e-05 | 7 | 205 | 3 | IPR032023 | |
| Domain | TPR_1 | 5.99e-05 | 90 | 205 | 7 | IPR001440 | |
| Domain | TPR_1 | 5.99e-05 | 90 | 205 | 7 | PF00515 | |
| Domain | TPR_REGION | 8.88e-05 | 165 | 205 | 9 | PS50293 | |
| Domain | TPR | 8.88e-05 | 165 | 205 | 9 | PS50005 | |
| Domain | IMP_DH | 1.20e-04 | 2 | 205 | 2 | IPR005990 | |
| Domain | ABC_membrane | 1.26e-04 | 24 | 205 | 4 | PF00664 | |
| Domain | Sp1_fam | 1.48e-04 | 10 | 205 | 3 | IPR030450 | |
| Domain | - | 1.48e-04 | 10 | 205 | 3 | 1.10.220.60 | |
| Domain | Grip | 2.01e-04 | 11 | 205 | 3 | SM00755 | |
| Domain | GRIP | 2.01e-04 | 11 | 205 | 3 | PF01465 | |
| Domain | ABC_TM1F | 2.35e-04 | 28 | 205 | 4 | PS50929 | |
| Domain | ABC1_TM_dom | 2.35e-04 | 28 | 205 | 4 | IPR011527 | |
| Domain | SMAD_FHA_domain | 2.59e-04 | 52 | 205 | 5 | IPR008984 | |
| Domain | GRIP_dom | 2.66e-04 | 12 | 205 | 3 | IPR000237 | |
| Domain | GRIP | 2.66e-04 | 12 | 205 | 3 | PS50913 | |
| Domain | - | RGPD4 SPTBN1 RGPD1 PLEKHM1 PLEKHH1 ARAP2 RGPD2 RANBP2 APBB2 ARHGEF12 TLN1 EPB41 MTMR9 | 4.00e-04 | 391 | 205 | 13 | 2.30.29.30 |
| Domain | DUF2012 | 7.09e-04 | 4 | 205 | 2 | PF09430 | |
| Domain | IMPDH | 7.09e-04 | 4 | 205 | 2 | PF00478 | |
| Domain | IMP_DH_GMPRt | 7.09e-04 | 4 | 205 | 2 | IPR001093 | |
| Domain | DDT | 7.09e-04 | 4 | 205 | 2 | PF02791 | |
| Domain | IMP_DH_GMP_RED | 7.09e-04 | 4 | 205 | 2 | PS00487 | |
| Domain | IMP_DH/GMP_Rdtase_CS | 7.09e-04 | 4 | 205 | 2 | IPR015875 | |
| Domain | DUF2012 | 7.09e-04 | 4 | 205 | 2 | IPR019008 | |
| Domain | CarboxyPept-like_regulatory | 7.91e-04 | 17 | 205 | 3 | IPR008969 | |
| Domain | PH_dom-like | RGPD4 SPTBN1 RGPD1 PLEKHM1 PLEKHH1 ARAP2 RGPD2 RANBP2 APBB2 ARHGEF12 TLN1 EPB41 MTMR9 | 8.88e-04 | 426 | 205 | 13 | IPR011993 |
| Domain | Kinesin_motor_CS | 1.04e-03 | 41 | 205 | 4 | IPR019821 | |
| Domain | AAA | 1.07e-03 | 144 | 205 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 1.07e-03 | 144 | 205 | 7 | IPR003593 | |
| Domain | TPR-like_helical_dom | 1.12e-03 | 233 | 205 | 9 | IPR011990 | |
| Domain | ABC_transporter_CS | 1.14e-03 | 42 | 205 | 4 | IPR017871 | |
| Domain | DDT | 1.17e-03 | 5 | 205 | 2 | SM00571 | |
| Domain | DDT_dom | 1.17e-03 | 5 | 205 | 2 | IPR018501 | |
| Domain | WHIM1_dom | 1.17e-03 | 5 | 205 | 2 | IPR028942 | |
| Domain | WHIM2_dom | 1.17e-03 | 5 | 205 | 2 | IPR028941 | |
| Domain | WSD | 1.17e-03 | 5 | 205 | 2 | PF15613 | |
| Domain | WHIM1 | 1.17e-03 | 5 | 205 | 2 | PF15612 | |
| Domain | Kinesin-like_fam | 1.24e-03 | 43 | 205 | 4 | IPR027640 | |
| Domain | - | 1.36e-03 | 44 | 205 | 4 | 3.40.850.10 | |
| Domain | Kinesin | 1.36e-03 | 44 | 205 | 4 | PF00225 | |
| Domain | KISc | 1.36e-03 | 44 | 205 | 4 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 1.36e-03 | 44 | 205 | 4 | PS00411 | |
| Domain | Kinesin_motor_dom | 1.36e-03 | 44 | 205 | 4 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 1.36e-03 | 44 | 205 | 4 | PS50067 | |
| Domain | DDT | 1.75e-03 | 6 | 205 | 2 | PS50827 | |
| Domain | MCM_N | 1.75e-03 | 6 | 205 | 2 | PF14551 | |
| Domain | MCM_CS | 1.75e-03 | 6 | 205 | 2 | IPR018525 | |
| Domain | MCM_N | 1.75e-03 | 6 | 205 | 2 | IPR027925 | |
| Domain | ABC_tran | 1.88e-03 | 48 | 205 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.88e-03 | 48 | 205 | 4 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 2.03e-03 | 49 | 205 | 4 | PS00211 | |
| Domain | - | 2.09e-03 | 207 | 205 | 8 | 1.25.40.10 | |
| Domain | ABC_transporter-like | 2.19e-03 | 50 | 205 | 4 | IPR003439 | |
| Pathway | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | 4.04e-06 | 11 | 152 | 4 | M2071 | |
| Pathway | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | 4.04e-06 | 11 | 152 | 4 | MM15425 | |
| Pathway | REACTOME_NUCLEOTIDE_BIOSYNTHESIS | 1.20e-05 | 14 | 152 | 4 | M27830 | |
| Pathway | REACTOME_NUCLEOTIDE_BIOSYNTHESIS | 1.20e-05 | 14 | 152 | 4 | MM15551 | |
| Pathway | REACTOME_SUMOYLATION | 1.46e-05 | 169 | 152 | 10 | MM14919 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 3.34e-05 | 84 | 152 | 7 | MM14929 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 3.53e-05 | 18 | 152 | 4 | MM1549 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 3.63e-05 | 58 | 152 | 6 | MM15149 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 6.96e-05 | 65 | 152 | 6 | MM15147 | |
| Pathway | WP_SELENIUM_METABOLISM_SELENOPROTEINS | 1.18e-04 | 45 | 152 | 5 | MM15877 | |
| Pathway | WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS | 1.45e-04 | 47 | 152 | 5 | M48301 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.15e-04 | 51 | 152 | 5 | MM15151 | |
| Pathway | WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS | 2.52e-04 | 12 | 152 | 3 | M48096 | |
| Pubmed | MCMBP IMPDH1 IMPDH2 SPTBN1 MCM4 MCM5 PFAS MARCKSL1 RSRC2 RRBP1 MDH2 TRIP12 MRPS22 PDCD4 FASN CGN EIF2S2 MKI67 SDHA WWC1 IPO5 RANBP2 CPSF6 WWP2 PPP6R1 MED1 TBL1XR1 RNF2 AKAP9 RUVBL1 MICAL2 EPHA2 TLN1 ATIC NFAT5 PCNA | 8.34e-15 | 1247 | 212 | 36 | 27684187 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | UIMC1 MIS18BP1 ZMYM2 DAXX GPATCH8 TRIP12 BPTF ATAD2B ZNF483 MKI67 ZNF770 BOD1L1 USP48 IPO5 SMC6 POU2F1 MED1 TBL1XR1 PHC1 RNF2 PSIP1 BAZ2A ARID2 CHD5 CDC27 RBM34 | 8.85e-15 | 608 | 212 | 26 | 36089195 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | UIMC1 IRF2BP2 IMPDH2 ZMYM2 MCM4 PFAS RRBP1 MDH2 PDCD4 FASN PRRC2C MKI67 BOD1L1 RANBP2 ANK2 CPSF6 PPP6R1 MED1 RBM12 RUVBL1 PSIP1 BAZ2A ARID2 TLN1 MACF1 ATIC PALLD EPB41 PCNA | 7.52e-13 | 934 | 212 | 29 | 33916271 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | UIMC1 SP1 IMPDH2 SPTBN1 ZMYM2 MCM4 DAXX GPATCH8 PDCD4 BPTF FASN BOD1L1 USP48 RANBP2 RUVBL1 ARID2 TLN1 PALLD | 2.86e-12 | 332 | 212 | 18 | 32786267 |
| Pubmed | UIMC1 IRF2BP2 MCMBP MIS18BP1 IMPDH2 GBE1 MCM4 MCM5 GPATCH8 RRBP1 BPTF FASN SERPINB5 EIF2S2 MKI67 BOD1L1 USP48 FUBP3 IPO5 RANBP2 SMC6 MED1 TBL1XR1 RBM12 RNF2 PSIP1 RTCA ATIC PCNA | 5.56e-12 | 1014 | 212 | 29 | 32416067 | |
| Pubmed | UIMC1 IRF2BP2 SP1 ERCC4 IMPDH2 SPTBN1 RGPD1 ZMYM2 TNIP1 GPATCH8 DCAF5 MRPS22 SEPTIN6 CNOT8 BPTF FHAD1 PRRC2C SPZ1 NFKB1 MKI67 ZNF770 FUBP3 ZNF703 HSPG2 POU2F1 PPP6R1 TBL1XR1 ZNF284 RBM12 RNF2 ARID2 CHD5 RBM34 PCNA | 1.09e-11 | 1429 | 212 | 34 | 35140242 | |
| Pubmed | IMPDH2 SPTBN1 MCM4 MCM5 PFAS URB2 TRIP12 BPTF FASN PRRC2C ATAD2B CGN MKI67 KIF14 FUBP3 SDHA IPO5 RANBP2 BAZ2A TLN1 MACF1 ATIC RBM34 | 1.75e-11 | 653 | 212 | 23 | 22586326 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | IMPDH2 SPTBN1 MCM4 MCM5 PFAS MARCKSL1 RRBP1 MDH2 PLAA PRRC2C EIF2S2 FUBP3 SDHA IPO5 RANBP2 CPSF6 SUN1 RBM12 TLN1 ATIC ADPGK PCNA | 2.86e-11 | 607 | 212 | 22 | 39147351 |
| Pubmed | UIMC1 IRF2BP2 UBTD2 SPTBN1 MCM4 DAXX URB2 FASN PRRC2C NFKB1 CLBA1 IPO5 RC3H2 THBS1 EYS TLN1 MACF1 | 2.89e-11 | 332 | 212 | 17 | 37433992 | |
| Pubmed | MCMBP IMPDH2 SPTBN1 PFAS TNIP1 MARCKSL1 RRBP1 MDH2 DCAF5 MRPS22 NOMO2 HINT2 USP48 HSPA6 SDHA ANK2 CAMLG WWP2 SUN1 KIF16B ZDHHC5 PPP6R1 ZDHHC17 AKAP9 PSIP1 BAZ2A GUSB EPHA2 DHRS7 TLN1 MACF1 M6PR TMCC1 RBM34 | 3.19e-11 | 1487 | 212 | 34 | 33957083 | |
| Pubmed | RGPD4 UIMC1 SCN11A UBTD2 TTC16 SPTBN1 RGPD1 MCM5 RRBP1 MDH2 TRIP12 ABCB1 BPTF FASN NRXN1 PRRC2C BOD1L1 KIF5C KIAA2012 FUBP3 HSPA6 RGPD2 RANBP2 CUX2 ANK2 ABCB5 ZDHHC17 RNF2 PSIP1 CHD5 MACF1 CDC27 PHTF1 | 6.31e-11 | 1442 | 212 | 33 | 35575683 | |
| Pubmed | IRF2BP2 SP4 IMPDH2 ZMYM2 GBE1 MCM4 MCM5 RSRC2 SEPTIN6 BPTF FASN PRRC2C EIF2S2 MKI67 ZNF770 FUBP3 RANBP2 CPSF6 POU2F1 MED1 TBL1XR1 RBM12 PSIP1 ARID2 TLN1 RPUSD2 BICRAL ATIC | 2.06e-10 | 1103 | 212 | 28 | 34189442 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ZMYM2 MCM4 TNIP1 RSRC2 RRBP1 FOXA2 TRIP12 BPTF FASN BHLHA15 PRRC2C NFKB1 EIF2S2 FUBP3 RANBP2 ZCWPW1 AGGF1 POU2F1 PPP6R1 TBL1XR1 RNF2 PSIP1 RTCA CDC27 | 6.55e-10 | 857 | 212 | 24 | 25609649 |
| Pubmed | URB2 GPATCH8 DCAF5 PLEKHH1 PRRC2C BOD1L1 TET3 ARAP2 ARHGEF12 PPP6R1 ZDHHC17 AKAP9 TENM3 BAZ2A TLN1 MACF1 NFAT5 | 6.67e-10 | 407 | 212 | 17 | 12693553 | |
| Pubmed | UIMC1 SP3 IMPDH1 IMPDH2 ZMYM2 MCM5 DAXX MARCKSL1 URB2 GPATCH8 RSRC2 MRPS22 CNOT8 EIF2S2 KIF14 HSPA6 IQGAP3 SDHA RANBP2 TBC1D30 CPSF6 ARHGEF12 MED1 TBL1XR1 RNF2 BAZ2A ARID2 TLN1 MACF1 CDC27 TMCC1 EPB41 | 6.93e-10 | 1497 | 212 | 32 | 31527615 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | IMPDH2 MCM4 MCM5 URB2 RRBP1 MDH2 TRIP12 ABCB1 BPTF FASN CGN MKI67 PEX5 HINT2 KIF14 FUBP3 IPO5 RANBP2 CPSF6 SUN1 RUVBL1 PSIP1 TLN1 MACF1 ATIC PCNA | 9.59e-10 | 1024 | 212 | 26 | 24711643 |
| Pubmed | 9.92e-10 | 9 | 212 | 5 | 17887960 | ||
| Pubmed | 9.92e-10 | 9 | 212 | 5 | 11553612 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | GRIPAP1 MCMBP IMPDH2 SPTBN1 ITGA6 MCM5 PFAS MARCKSL1 MDH2 MRPS22 FASN SERPINB5 PLAA NFKB1 FUBP3 RANBP2 CPSF6 TBL1XR1 OXCT1 RUVBL1 EPHA2 DHRS7 TLN1 RTCA ATIC CDC27 M6PR PALLD EPB41 PCNA | 1.37e-09 | 1367 | 212 | 30 | 32687490 |
| Pubmed | 6.68e-09 | 5 | 212 | 4 | 20538607 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | IRF2BP2 IMPDH2 SPTBN1 ITGA6 MCM4 MCM5 PFAS MDH2 SBSN FASN CGN FUBP3 HSPA6 SDHA RANBP2 TLN1 ATIC | 7.18e-09 | 477 | 212 | 17 | 31300519 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MCMBP IMPDH2 SPTBN1 MCM4 MCM5 PFAS URB2 RRBP1 MDH2 PLA2G15 FASN EIF2S2 MKI67 KIF14 BOD1L1 FUBP3 IQGAP3 SDHA IPO5 RANBP2 CPSF6 SMC6 RNF2 RUVBL1 PSIP1 TLN1 ATIC RBM34 PCNA | 1.41e-08 | 1425 | 212 | 29 | 30948266 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | SPTBN1 RGPD1 ZMYM2 MCM4 RRBP1 BPTF MKI67 RGPD2 RANBP2 ANK2 CPSF6 MED1 CHD5 | 1.42e-08 | 271 | 212 | 13 | 32433965 |
| Pubmed | SPTBN1 E2F7 TRIP12 SBSN FASN MKI67 BOD1L1 KIAA2012 FUBP3 RANBP2 RNF2 RUVBL1 PALLD | 1.49e-08 | 272 | 212 | 13 | 31010829 | |
| Pubmed | TNIP1 ADGRV1 RRBP1 ZNF518A NRXN1 AKAP6 PRUNE2 CUX2 RBM12 CHD5 TLN1 MACF1 | 1.61e-08 | 225 | 212 | 12 | 12168954 | |
| Pubmed | IMPDH2 SPTBN1 MCM4 RRBP1 FASN PRRC2C BOD1L1 SDHA IPO5 RANBP2 ANK2 ZDHHC5 ARHGEF12 RUVBL1 EPHA2 TLN1 MACF1 CDC27 PALLD EPB41 | 1.64e-08 | 708 | 212 | 20 | 39231216 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MIS18BP1 IMPDH2 SPTBN1 MCM4 MCM5 PFAS URB2 RRBP1 TRIP12 FASN PLAA EIF2S2 MKI67 FUBP3 HSPA6 RANBP2 OXCT1 RUVBL1 BAZ2A MICAL2 TLN1 RTCA MACF1 ATIC CDC27 PALLD RBM34 PCNA | 1.80e-08 | 1353 | 212 | 28 | 29467282 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | IRF2BP2 GRIPAP1 MCMBP IMPDH1 IMPDH2 SPTBN1 MCM4 MCM5 PFAS COG3 PDCD4 FASN PLAA EIF2S2 PEX5 USP48 FUBP3 HSPA6 IPO5 PRUNE2 TBL1XR1 RBM12 OXCT1 RUVBL1 TLN1 RPUSD2 MACF1 ATIC PCNA | 2.21e-08 | 1455 | 212 | 29 | 22863883 |
| Pubmed | IMPDH1 SPTBN1 MARCKSL1 RSRC2 RRBP1 MDH2 TRIP12 SBSN SEPTIN6 FASN BHLHA15 PRRC2C CGN MKI67 FUBP3 RC3H2 ANK2 CPSF6 WWP2 MED1 RNF2 AKAP9 RUVBL1 PSIP1 EPHA2 TLN1 RBM34 PCNA | 2.38e-08 | 1371 | 212 | 28 | 36244648 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | UIMC1 MIS18BP1 ERCC4 IMPDH2 SPTBN1 ZMYM2 ITGA6 URB2 GPATCH8 FOXA2 SBSN ZNF518A FASN MKI67 HINT2 IPO5 RANBP2 CAMLG SUN1 SMC6 ZDHHC5 PSIP1 MICAL2 DHRS7 M6PR ADPGK | 2.58e-08 | 1203 | 212 | 26 | 29180619 |
| Pubmed | RGPD4 GRIPAP1 SPTBN1 RGPD1 MARCKSL1 RRBP1 SEPTIN6 SERPINB5 PLAA NRXN1 PRRC2C SDHA CACNA1B RGPD2 RANBP2 ANK2 CPSF6 CAMLG SUN1 PPP6R1 OXCT1 RUVBL1 MACF1 TMCC1 EPB41 | 3.64e-08 | 1139 | 212 | 25 | 36417873 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | RGPD4 RGPD1 ZMYM2 MCM4 TRIP12 PRRC2C RGPD2 RANBP2 RUVBL1 PCNA | 3.85e-08 | 153 | 212 | 10 | 26365490 |
| Pubmed | GRIPAP1 IMPDH2 SPTBN1 MCM4 MCM5 RRBP1 PDCD4 SEPTIN6 EIF2S2 MKI67 CPSF6 RUVBL1 TLN1 MACF1 PALLD EPB41 PCNA | 4.14e-08 | 538 | 212 | 17 | 28524877 | |
| Pubmed | 4.63e-08 | 7 | 212 | 4 | 9037092 | ||
| Pubmed | 4.63e-08 | 7 | 212 | 4 | 21205196 | ||
| Pubmed | 4.63e-08 | 7 | 212 | 4 | 24403063 | ||
| Pubmed | 4.63e-08 | 7 | 212 | 4 | 23536549 | ||
| Pubmed | 4.63e-08 | 7 | 212 | 4 | 12191015 | ||
| Pubmed | 4.63e-08 | 7 | 212 | 4 | 22821000 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 4.63e-08 | 7 | 212 | 4 | 11353387 | |
| Pubmed | 4.63e-08 | 7 | 212 | 4 | 30944974 | ||
| Pubmed | 4.63e-08 | 7 | 212 | 4 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 4.63e-08 | 7 | 212 | 4 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 4.63e-08 | 7 | 212 | 4 | 17372272 | |
| Pubmed | 4.63e-08 | 7 | 212 | 4 | 38657106 | ||
| Pubmed | 4.63e-08 | 7 | 212 | 4 | 18949001 | ||
| Pubmed | 4.63e-08 | 7 | 212 | 4 | 25187515 | ||
| Pubmed | 4.63e-08 | 7 | 212 | 4 | 8603673 | ||
| Pubmed | 4.63e-08 | 7 | 212 | 4 | 26632511 | ||
| Pubmed | 4.63e-08 | 7 | 212 | 4 | 23818861 | ||
| Pubmed | 4.63e-08 | 7 | 212 | 4 | 20682751 | ||
| Pubmed | RGPD1 PFAS RRBP1 PEX5 WWC1 RC3H2 ARHGEF12 PPP6R1 EPHA2 MACF1 PALLD | 7.40e-08 | 209 | 212 | 11 | 36779422 | |
| Pubmed | UIMC1 IMPDH2 GPATCH8 RRBP1 MRPS22 SBSN SERPINB5 PLAA MKI67 IPO5 TBL1XR1 MICAL2 ARID2 TLN1 MACF1 ATIC CDC27 RBM34 | 8.17e-08 | 634 | 212 | 18 | 34591612 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 9.22e-08 | 8 | 212 | 4 | 21670213 | |
| Pubmed | 9.22e-08 | 8 | 212 | 4 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 9.22e-08 | 8 | 212 | 4 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 9.22e-08 | 8 | 212 | 4 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 9.22e-08 | 8 | 212 | 4 | 28745977 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | DAXX RRBP1 TRIP12 CNOT8 PRRC2C MKI67 FUBP3 ZNF703 RC3H2 RANBP2 SMC6 MED1 RNF2 RUVBL1 EPHA2 TLN1 MACF1 CDC27 PALLD | 1.19e-07 | 724 | 212 | 19 | 36232890 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | UIMC1 GRIPAP1 MCMBP MIS18BP1 E2F7 ZMYM2 PFAS TNIP1 DAXX NOMO2 PRRC2C KIF14 ZNF703 PPP6R1 ARID2 MACF1 TEDC1 | 1.47e-07 | 588 | 212 | 17 | 38580884 |
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 1.58e-07 | 135 | 212 | 9 | 31077711 | |
| Pubmed | 1.65e-07 | 9 | 212 | 4 | 28100513 | ||
| Pubmed | 1.65e-07 | 9 | 212 | 4 | 9733766 | ||
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 1.65e-07 | 9 | 212 | 4 | 18394993 | |
| Pubmed | 1.65e-07 | 9 | 212 | 4 | 10601307 | ||
| Pubmed | 1.65e-07 | 9 | 212 | 4 | 28877029 | ||
| Pubmed | IRF2BP2 GPATCH8 PRRC2C MKI67 BOD1L1 FUBP3 ZNF703 CPSF6 MED1 RBM12 RUVBL1 PSIP1 PALLD PCNA | 1.92e-07 | 399 | 212 | 14 | 35987950 | |
| Pubmed | 1.94e-07 | 22 | 212 | 5 | 27717094 | ||
| Pubmed | Curcumin decreases specificity protein expression in bladder cancer cells. | 2.23e-07 | 3 | 212 | 3 | 18593936 | |
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 21919647 | ||
| Pubmed | Complex phenotype of mice homozygous for a null mutation in the Sp4 transcription factor gene. | 2.23e-07 | 3 | 212 | 3 | 11532028 | |
| Pubmed | Functional analyses of the transcription factor Sp4 reveal properties distinct from Sp1 and Sp3. | 2.23e-07 | 3 | 212 | 3 | 7559627 | |
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 17652716 | ||
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 23540600 | ||
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 26967243 | ||
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 23464785 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | IMPDH2 SPTBN1 GBE1 MCM4 PFAS MDH2 FASN NOMO2 IPO5 CPSF6 TLN1 NOMO3 PCNA | 2.28e-07 | 344 | 212 | 13 | 30333137 |
| Pubmed | ABCC4 IMPDH2 MCM4 MCM5 FASN ATP8A1 PIK3CG PRRC2C MKI67 KIF14 FUBP3 IPO5 RANBP2 CPSF6 CAMLG WWP2 ZDHHC5 MED1 GUSB DHRS7 CHD5 ATIC M6PR ADPGK | 2.32e-07 | 1168 | 212 | 24 | 19946888 | |
| Pubmed | IRF2BP2 IMPDH2 SPTBN1 GBE1 MCM5 COG3 MDH2 MRPS22 PDCD4 FASN PRRC2C NFKB1 EIF2S2 MKI67 KIF14 FUBP3 HSPA6 SDHA IPO5 RANBP2 PPP6R1 OXCT1 PSIP1 GUSB TLN1 RBM34 PCNA | 2.39e-07 | 1440 | 212 | 27 | 30833792 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | IMPDH2 URB2 RRBP1 TRIP12 MRPS22 BPTF PRRC2C EIF2S2 MKI67 IQGAP3 SMC6 AGGF1 MED1 RUVBL1 PSIP1 ARID2 MACF1 RBM34 PCNA | 2.45e-07 | 759 | 212 | 19 | 35915203 |
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 2.74e-07 | 10 | 212 | 4 | 16332688 | |
| Pubmed | 2.74e-07 | 10 | 212 | 4 | 27160050 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 2.74e-07 | 10 | 212 | 4 | 8857542 | |
| Pubmed | 2.74e-07 | 10 | 212 | 4 | 21859863 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 3.08e-07 | 146 | 212 | 9 | 23892456 | |
| Pubmed | TNIP1 BPTF FASN PRRC2C CGN KIF14 BOD1L1 HSPA6 MED1 RNF2 RUVBL1 BAZ2A ARID2 TLN1 PALLD EPB41 | 3.11e-07 | 549 | 212 | 16 | 38280479 | |
| Pubmed | IMPDH2 SPTBN1 E2F7 MCM5 RRBP1 MDH2 PDCD4 FASN PRRC2C EIF2S2 FUBP3 CPSF6 RUVBL1 RBM34 PCNA ALG13 | 3.26e-07 | 551 | 212 | 16 | 34728620 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ABCC4 ITGA6 RRBP1 PLA2G15 MRPS22 NXPE3 NEK4 MELTF NOMO2 USP48 HSPG2 CAMLG SUN1 PPP6R1 THBS1 RUVBL1 TENM3 MICAL2 GUSB EPHA2 NAGPA M6PR PALLD ADPGK | 3.83e-07 | 1201 | 212 | 24 | 35696571 |
| Pubmed | A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway. | TNIP1 MDH2 MELTF SERPINB5 KIF14 KIF5C FUBP3 IQGAP3 RANBP2 TENM3 SHARPIN TEDC1 | 3.95e-07 | 302 | 212 | 12 | 30561431 |
| Pubmed | 4.09e-07 | 151 | 212 | 9 | 17043677 | ||
| Pubmed | 4.28e-07 | 11 | 212 | 4 | 17069463 | ||
| Pubmed | 4.28e-07 | 11 | 212 | 4 | 34110283 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 4.28e-07 | 11 | 212 | 4 | 35771867 | |
| Pubmed | 4.28e-07 | 11 | 212 | 4 | 1574589 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | UIMC1 ZMYM2 MCM4 RRBP1 TRIP12 BPTF PRRC2C ATAD2B EIF2S2 MKI67 BOD1L1 FUBP3 RANBP2 CPSF6 SMC6 MED1 RUVBL1 PSIP1 BAZ2A ARID2 EPB41 | 4.61e-07 | 954 | 212 | 21 | 36373674 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SP1 SP3 SP4 KDM5D TRIP12 TMEM132C ZNF469 PEX5 NYAP1 PRUNE2 CUX2 ARID2 CHD5 TLN1 | 4.71e-07 | 430 | 212 | 14 | 35044719 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | IMPDH2 RRBP1 TRIP12 FASN PRRC2C IQGAP3 IPO5 MED1 THBS1 ADPGK | 5.15e-07 | 202 | 212 | 10 | 33005030 |
| Pubmed | TRAIP regulates replication fork recovery and progression via PCNA. | 5.81e-07 | 27 | 212 | 5 | 27462463 | |
| Pubmed | MCM5 RRBP1 DCAF5 MRPS22 ABCB1 FASN PLAA PRRC2C EIF2S2 HSPA6 IQGAP3 SDHA IPO5 ANK2 CPSF6 ARHGEF12 RUVBL1 RTCA CDC27 RBM34 PCNA | 6.12e-07 | 971 | 212 | 21 | 33306668 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 RGPD1 ZMYM2 RRBP1 MRPS22 CNOT8 FASN SERPINB5 PLAA MKI67 KIF14 IQGAP3 IPO5 RGPD2 RANBP2 SMC6 AGGF1 THBS1 RUVBL1 ARID2 TLN1 CDC27 PCNA | 7.23e-07 | 1155 | 212 | 23 | 20360068 |
| Interaction | CEBPB interactions | RGPD4 SP1 SP3 IMPDH1 IMPDH2 GBE1 MCM4 MCM5 DAXX MARCKSL1 GPATCH8 COG3 RRBP1 MDH2 MRPS22 NEK4 BPTF FASN PRRC2C NFKB1 EIF2S2 MKI67 KIF14 FUBP3 HSPA6 SDHA IPO5 RANBP2 POU2F1 MED1 TBL1XR1 AKAP9 RUVBL1 PSIP1 BAZ2A TLN1 ATIC CDC27 NFAT5 PALLD | 1.07e-08 | 1443 | 210 | 40 | int:CEBPB |
| Interaction | H3C3 interactions | UIMC1 MIS18BP1 ZMYM2 DAXX TRIP12 BPTF ATAD2B MKI67 BOD1L1 USP48 IPO5 SMC6 POU2F1 MED1 TBL1XR1 PHC1 RNF2 BAZ2A ARID2 CHD5 CDC27 RBM34 | 1.18e-08 | 495 | 210 | 22 | int:H3C3 |
| Interaction | SUMO2 interactions | UIMC1 SP1 ERCC4 IMPDH2 SPTBN1 ZMYM2 MCM4 TNIP1 DAXX GPATCH8 TRIP12 PDCD4 BPTF FASN MKI67 BOD1L1 USP48 IPO5 RANBP2 RUVBL1 ARID2 TLN1 ATIC PALLD | 1.41e-08 | 591 | 210 | 24 | int:SUMO2 |
| Interaction | H3C1 interactions | UIMC1 ZMYM2 MCM4 MCM5 TNIP1 DAXX RRBP1 MDH2 TRIP12 MRPS22 PDCD4 BPTF AURKC PRRC2C MKI67 USP48 WWC1 IPO5 ANK2 SMC6 THBS1 RNF2 PSIP1 BAZ2A ARID2 CDC27 PALLD RBM34 PCNA | 6.75e-08 | 901 | 210 | 29 | int:H3C1 |
| Interaction | H3-3A interactions | UIMC1 ZMYM2 MCM5 DAXX GPATCH8 TRIP12 BPTF ASB9 ATAD2B ZNF483 MKI67 ZNF770 BOD1L1 USP48 IPO5 SMC6 POU2F1 MED1 RNF2 RUVBL1 PSIP1 BAZ2A ARID2 CHD5 CDC27 RBM34 | 7.96e-08 | 749 | 210 | 26 | int:H3-3A |
| Interaction | MEX3A interactions | UIMC1 IRF2BP2 UBTD2 SPTBN1 MCM4 DAXX URB2 FASN PRRC2C NFKB1 FUBP3 CLBA1 IPO5 RC3H2 THBS1 EYS TLN1 MACF1 | 1.22e-07 | 384 | 210 | 18 | int:MEX3A |
| Interaction | ATF7IP interactions | SP1 SPTBN1 ZMYM2 DAXX RRBP1 TRIP12 ZNF518A PKD1 HSPG2 MACF1 NOMO3 | 2.19e-07 | 138 | 210 | 11 | int:ATF7IP |
| Interaction | NAA40 interactions | UIMC1 IRF2BP2 IMPDH2 ZMYM2 MCM4 PFAS RRBP1 MDH2 PDCD4 FASN PRRC2C MKI67 BOD1L1 RANBP2 ANK2 CPSF6 PPP6R1 MED1 RBM12 RUVBL1 PSIP1 BAZ2A ARID2 TLN1 MACF1 ATIC PALLD EPB41 PCNA | 3.77e-07 | 978 | 210 | 29 | int:NAA40 |
| Interaction | NUMA1 interactions | MCMBP IMPDH2 MCM4 TNIP1 TRIP12 ATAD2B MKI67 KIF14 GPSM2 IPO5 RANBP2 WWP2 RNF2 RUVBL1 PSIP1 TLN1 MACF1 CDC27 EPB41 | 5.10e-07 | 469 | 210 | 19 | int:NUMA1 |
| Interaction | CFTR interactions | RGPD4 ABCC4 IMPDH2 SPTBN1 RGPD1 MCM4 MARCKSL1 RRBP1 MDH2 TRIP12 SEPTIN6 MELTF FASN BHLHA15 PRRC2C CGN EIF2S2 PKD1 HINT2 ZNF770 KIF5C HSPA6 IQGAP3 SDHA AKAP6 IPO5 RGPD2 RANBP2 SPATA6L WWP2 THBS1 RUVBL1 UNC45B TLN1 MACF1 PCP4L1 PCNA | 5.54e-07 | 1480 | 210 | 37 | int:CFTR |
| Interaction | SIRT7 interactions | IMPDH2 SPTBN1 MCM4 MCM5 PFAS URB2 TRIP12 DCAF5 BPTF FASN PRRC2C ATAD2B CGN MKI67 KIF14 FUBP3 SDHA IPO5 RANBP2 BAZ2A TLN1 MACF1 ATIC RBM34 | 9.70e-07 | 744 | 210 | 24 | int:SIRT7 |
| Interaction | KCNA3 interactions | IMPDH2 SPTBN1 MCM4 RSRC2 RRBP1 FASN PRRC2C CGN BOD1L1 IQGAP3 SDHA IPO5 CACNA1B RANBP2 ANK2 ZDHHC5 ARHGEF12 PRRT2 RUVBL1 EPHA2 TLN1 MACF1 CDC27 PALLD EPB41 PHTF1 | 1.42e-06 | 871 | 210 | 26 | int:KCNA3 |
| Interaction | H2AZ1 interactions | ZMYM2 MCM5 TNIP1 NEK4 BPTF FASN ASB9 KIF14 USP48 RC3H2 RNF2 RUVBL1 PSIP1 BAZ2A ARID2 CDC27 | 1.88e-06 | 371 | 210 | 16 | int:H2AZ1 |
| Interaction | CEBPA interactions | IRF2BP2 SP4 IMPDH2 SPTBN1 ZMYM2 GBE1 MCM4 MCM5 RSRC2 SEPTIN6 BPTF FASN PRRC2C EIF2S2 MKI67 ZNF770 FUBP3 RANBP2 CPSF6 POU2F1 MED1 TBL1XR1 RBM12 AKAP9 PSIP1 ARID2 TLN1 SHARPIN RPUSD2 MACF1 BICRAL ATIC | 2.02e-06 | 1245 | 210 | 32 | int:CEBPA |
| Interaction | BRCA1 interactions | UIMC1 SP1 ERCC4 IMPDH2 SPTBN1 MCM4 MCM5 MARCKSL1 MDH2 BPTF AURKC FASN PLAA NFKB1 MKI67 PEX5 USP48 IPO5 CPSF6 SMC6 ZDHHC5 POU2F1 GUSBP1 PPP6R1 TBL1XR1 RUVBL1 ZNF827 MICAL2 TLN1 CDC27 PALLD PCNA | 2.17e-06 | 1249 | 210 | 32 | int:BRCA1 |
| Interaction | H2BC3 interactions | SPTBN1 ZMYM2 MCM4 MCM5 DAXX RRBP1 TRIP12 USP48 RC3H2 RANBP2 MED1 RNF2 RUVBL1 ARID2 CDC27 PCNA | 5.94e-06 | 406 | 210 | 16 | int:H2BC3 |
| Interaction | PFN1 interactions | SPTBN1 TNIP1 MDH2 FASN ATP8A1 KIF14 BOD1L1 USP48 SDHA RANBP2 ANK2 CPSF6 ARHGEF12 AKAP9 CHD5 MACF1 PALLD ALG13 | 6.90e-06 | 509 | 210 | 18 | int:PFN1 |
| Interaction | GSK3A interactions | TTC16 RGPD1 PFAS RRBP1 SBSN EIF2S2 PEX5 WWC1 RC3H2 ARHGEF12 PPP6R1 ZDHHC17 AKAP9 MACF1 PRKCH ATIC PALLD | 7.91e-06 | 464 | 210 | 17 | int:GSK3A |
| Interaction | BAG2 interactions | IRF2BP2 SP1 IMPDH2 TNIP1 NEK4 BPTF PRRC2C KIF14 BOD1L1 ZNF703 RC3H2 WWP2 KIF16B POU2F1 TBL1XR1 PHC1 CHD5 TLN1 SHARPIN PALLD | 8.61e-06 | 622 | 210 | 20 | int:BAG2 |
| Interaction | RGPD3 interactions | 8.96e-06 | 47 | 210 | 6 | int:RGPD3 | |
| Interaction | TRIM28 interactions | MCMBP IMPDH2 MCM4 MCM5 PFAS TNIP1 DAXX URB2 TRIP12 MRPS22 ZNF518A NEK4 FASN NFKB1 ZNF483 EIF2S2 MKI67 KIF14 KIF5C USP48 FUBP3 IQGAP3 IPO5 RC3H2 RANBP2 WWP2 TBL1XR1 ZNF284 ZNF17 OXCT1 RNF2 RUVBL1 RTCA PCNA | 9.83e-06 | 1474 | 210 | 34 | int:TRIM28 |
| Interaction | CAPZB interactions | UIMC1 SP1 MCMBP IMPDH2 SPTBN1 MCM4 TNIP1 RRBP1 MDH2 MRPS22 PDCD4 CNOT8 FASN PRRC2C NFKB1 EIF2S2 MKI67 KIF14 USP48 FUBP3 IPO5 RC3H2 WWP2 TBL1XR1 RUVBL1 BAZ2A CDC27 | 1.36e-05 | 1049 | 210 | 27 | int:CAPZB |
| Interaction | PARP1 interactions | UIMC1 IRF2BP2 SP1 ERCC4 IMPDH1 IMPDH2 MCM4 MCM5 TNIP1 DAXX URB2 MDH2 TRIP12 NEK4 BPTF FASN NFKB1 EIF2S2 MKI67 USP48 IQGAP3 IPO5 CPSF6 WWP2 POU2F1 MED1 PHC1 RNF2 PSIP1 RBM34 PCNA | 1.70e-05 | 1316 | 210 | 31 | int:PARP1 |
| Interaction | DBF4 interactions | 2.55e-05 | 34 | 210 | 5 | int:DBF4 | |
| Interaction | YAP1 interactions | MCMBP IMPDH2 SPTBN1 RRBP1 MDH2 BPTF FASN PRRC2C KIF14 BOD1L1 HSPA6 WWC1 IPO5 CPSF6 WWP2 MED1 THBS1 RNF2 RUVBL1 BAZ2A ARID2 TLN1 SHARPIN NFAT5 PALLD EPB41 PCNA | 2.88e-05 | 1095 | 210 | 27 | int:YAP1 |
| Interaction | SOX2 interactions | IRF2BP2 IMPDH2 SPTBN1 ZMYM2 GBE1 MDH2 TRIP12 DCAF5 MRPS22 ITIH4 BPTF SERPINB5 EIF2S2 KIF14 BOD1L1 FUBP3 IQGAP3 IPO5 RANBP2 WWP2 POU2F1 PPP6R1 MED1 TBL1XR1 THBS1 OXCT1 RNF2 RUVBL1 PSIP1 ARID2 MACF1 RBM34 | 3.03e-05 | 1422 | 210 | 32 | int:SOX2 |
| Interaction | OTUD7A interactions | 3.07e-05 | 58 | 210 | 6 | int:OTUD7A | |
| Interaction | CDC5L interactions | SPTBN1 MCM4 MCM5 TNIP1 NEK4 FASN EIF2S2 KIF14 HSPA6 WWC1 AKAP6 IPO5 RC3H2 RANBP2 CPSF6 WWP2 RNF2 AKAP9 RUVBL1 TLN1 MACF1 BICRAL CDC27 | 3.15e-05 | 855 | 210 | 23 | int:CDC5L |
| Interaction | NUP43 interactions | MIS18BP1 ZMYM2 GPATCH8 TRIP12 ZNF518A BPTF ATP8A1 PRRC2C ATAD2B MKI67 BOD1L1 HSPA6 ZNF703 RANBP2 RNF2 RUVBL1 PSIP1 BAZ2A ARID2 | 3.15e-05 | 625 | 210 | 19 | int:NUP43 |
| Interaction | SIRT6 interactions | IRF2BP2 ERCC4 IMPDH2 MCM4 MCM5 DAXX GPATCH8 RRBP1 TRIP12 MKI67 USP48 IQGAP3 RANBP2 MED1 TBL1XR1 RUVBL1 ARID2 CDC27 PALLD | 3.37e-05 | 628 | 210 | 19 | int:SIRT6 |
| Interaction | HDAC1 interactions | SP1 SP3 ZMYM2 MCM4 TNIP1 DAXX BPTF FASN SERPINB5 NFKB1 MKI67 KIF14 HSPA6 IPO5 RANBP2 WWP2 POU2F1 PPP6R1 TBL1XR1 RNF2 AKAP9 RUVBL1 ZNF827 BAZ2A CHD5 TLN1 PCNA | 3.54e-05 | 1108 | 210 | 27 | int:HDAC1 |
| Interaction | H2BC21 interactions | UIMC1 ZMYM2 MCM4 MCM5 TNIP1 DAXX TRIP12 PDCD4 BPTF MKI67 WWP2 TBL1XR1 PHC1 RNF2 RUVBL1 PSIP1 ARID2 TLN1 CDC27 PCNA | 4.29e-05 | 696 | 210 | 20 | int:H2BC21 |
| Interaction | FMR1 interactions | KIF21B SPTBN1 TNIP1 PRRC2C MKI67 KIF14 KIF5C FUBP3 RC3H2 RANBP2 WWP2 TBL1XR1 AKAP9 SHARPIN MACF1 CDC27 ALG13 | 4.95e-05 | 536 | 210 | 17 | int:FMR1 |
| Interaction | LRRC31 interactions | IMPDH2 RRBP1 TRIP12 FASN PRRC2C IQGAP3 IPO5 MED1 THBS1 ADPGK | 6.04e-05 | 205 | 210 | 10 | int:LRRC31 |
| Interaction | HCFC1 interactions | SP1 RRBP1 NEK4 PRRC2C MKI67 BOD1L1 NYAP1 CPSF6 WWP2 POU2F1 RUVBL1 PSIP1 | 6.16e-05 | 293 | 210 | 12 | int:HCFC1 |
| Interaction | RNF4 interactions | UIMC1 SP1 UBTD2 MIS18BP1 ERCC4 IMPDH1 IMPDH2 SPTBN1 ZMYM2 ITGA6 DAXX URB2 GPATCH8 FOXA2 SBSN ZNF518A FASN MKI67 HINT2 IPO5 RANBP2 CAMLG SUN1 SMC6 ZDHHC5 PHC1 PSIP1 MICAL2 DHRS7 M6PR ADPGK | 6.49e-05 | 1412 | 210 | 31 | int:RNF4 |
| Interaction | SYNCRIP interactions | KIF21B MCM5 TNIP1 MDH2 NEK4 PRRC2C MKI67 KIF14 USP48 FUBP3 HSPA6 RC3H2 CPSF6 WWP2 APBB2 FBH1 RNF2 TLN1 MACF1 ALG13 | 6.97e-05 | 721 | 210 | 20 | int:SYNCRIP |
| Interaction | TERF2IP interactions | UIMC1 ERCC4 ZMYM2 RSRC2 TRIP12 PDCD4 BPTF MKI67 BOD1L1 USP48 MED1 TBL1XR1 PHC1 CRYBB1 PSIP1 BAZ2A RPUSD2 | 7.11e-05 | 552 | 210 | 17 | int:TERF2IP |
| Interaction | RGPD4 interactions | 7.23e-05 | 22 | 210 | 4 | int:RGPD4 | |
| Interaction | DHX15 interactions | MCMBP IMPDH1 IMPDH2 MCM5 TNIP1 NEK4 FASN NFKB1 KIF14 HSPA6 IPO5 RC3H2 RANBP2 WWP2 AGGF1 PCNA | 7.82e-05 | 502 | 210 | 16 | int:DHX15 |
| Interaction | CACNB2 interactions | 8.69e-05 | 23 | 210 | 4 | int:CACNB2 | |
| Interaction | AP3B2 interactions | 1.02e-04 | 45 | 210 | 5 | int:AP3B2 | |
| Interaction | HDAC2 interactions | IRF2BP2 SP1 SP3 ZMYM2 MCM5 DAXX BPTF PRRC2C NFKB1 MKI67 KIF14 FUBP3 SDHA IPO5 HSPG2 WWP2 TBL1XR1 PHC1 RNF2 RUVBL1 ZNF827 CHD5 | 1.07e-04 | 865 | 210 | 22 | int:HDAC2 |
| Interaction | GATA4 interactions | SP1 IMPDH2 ZMYM2 KDM5D BPTF HSPA6 MED1 TBL1XR1 PHC1 RNF2 RUVBL1 PSIP1 BAZ2A CDC27 | 1.10e-04 | 411 | 210 | 14 | int:GATA4 |
| Interaction | GSK3B interactions | SP1 IMPDH2 RGPD1 PFAS RRBP1 MDH2 TRIP12 FASN PRRC2C NFKB1 MKI67 PEX5 USP48 WWC1 IPO5 RC3H2 ARHGEF12 PPP6R1 EPHA2 MACF1 ATIC PALLD | 1.12e-04 | 868 | 210 | 22 | int:GSK3B |
| Interaction | SLC1A2 interactions | 1.13e-04 | 46 | 210 | 5 | int:SLC1A2 | |
| Interaction | LARP1 interactions | GRIPAP1 MCMBP IMPDH2 SPTBN1 MCM5 TNIP1 BHLHA15 NFKB1 CGN KIF14 USP48 IPO5 RC3H2 WWP2 RNF2 | 1.15e-04 | 465 | 210 | 15 | int:LARP1 |
| Interaction | H2BC8 interactions | UIMC1 MIS18BP1 ERCC4 ZMYM2 RSRC2 TRIP12 PDCD4 BPTF MKI67 USP48 SDHA PHC1 RNF2 PSIP1 BAZ2A RPUSD2 RBM34 | 1.19e-04 | 576 | 210 | 17 | int:H2BC8 |
| Interaction | IPO5 interactions | MCMBP IMPDH2 TNIP1 RRBP1 FASN MKI67 KIF14 IPO5 RANBP2 CPSF6 WWP2 POU2F1 AKAP9 ATIC | 1.19e-04 | 414 | 210 | 14 | int:IPO5 |
| Interaction | MOB3C interactions | MCM4 MCM5 TNIP1 TRIP12 FASN CGN EIF2S2 IPO5 RANBP2 PPP6R1 RUVBL1 TLN1 PCNA | 1.22e-04 | 364 | 210 | 13 | int:MOB3C |
| Interaction | RGPD8 interactions | 1.22e-04 | 74 | 210 | 6 | int:RGPD8 | |
| Interaction | ALG13 interactions | 1.33e-04 | 183 | 210 | 9 | int:ALG13 | |
| Interaction | FBL interactions | MCM5 TNIP1 RRBP1 MRPS22 PRRC2C EIF2S2 MKI67 KIF14 FUBP3 IPO5 RC3H2 WWP2 RNF2 RUVBL1 BAZ2A RTCA RBM34 ALG13 | 1.34e-04 | 639 | 210 | 18 | int:FBL |
| Interaction | ESRP1 interactions | 1.53e-04 | 77 | 210 | 6 | int:ESRP1 | |
| Interaction | TRAIP interactions | 1.53e-04 | 77 | 210 | 6 | int:TRAIP | |
| Interaction | OGT interactions | SP1 IMPDH1 IMPDH2 RSRC2 TRIP12 PDCD4 EIF2S2 MKI67 BOD1L1 FUBP3 IPO5 ZNF703 RC3H2 CPSF6 WWP2 TBL1XR1 OXCT1 RNF2 RUVBL1 PSIP1 ATIC ADPGK TEDC1 | 1.53e-04 | 950 | 210 | 23 | int:OGT |
| Interaction | CBX3 interactions | UIMC1 MIS18BP1 ZMYM2 DAXX TRIP12 ZNF518A FASN ZNF483 MKI67 KIF14 MED1 OXCT1 RNF2 PSIP1 BAZ2A ARID2 CHD5 MACF1 | 1.54e-04 | 646 | 210 | 18 | int:CBX3 |
| Interaction | RGPD1 interactions | 1.54e-04 | 49 | 210 | 5 | int:RGPD1 | |
| Interaction | LDHA interactions | IMPDH2 SLC24A3 TNIP1 MARCKSL1 MDH2 ASB9 MKI67 USP48 SDHA ANK2 RNF2 ATIC PCNA | 1.64e-04 | 375 | 210 | 13 | int:LDHA |
| Interaction | RGPD2 interactions | 1.67e-04 | 27 | 210 | 4 | int:RGPD2 | |
| Interaction | OBSL1 interactions | MCM5 TNIP1 DAXX URB2 MDH2 TRIP12 FASN CGN MKI67 KIF14 FUBP3 PRUNE2 CACNA1B RANBP2 CPSF6 SUN1 RUVBL1 PSIP1 TLN1 MACF1 RBM34 PCNA | 1.94e-04 | 902 | 210 | 22 | int:OBSL1 |
| Interaction | WDR76 interactions | IMPDH1 SPTBN1 MCM4 MCM5 TRIP12 MKI67 USP48 NPNT HSPG2 RANBP2 CPSF6 WWP2 PCNA | 2.01e-04 | 383 | 210 | 13 | int:WDR76 |
| Interaction | TSNAX interactions | 2.06e-04 | 194 | 210 | 9 | int:TSNAX | |
| Interaction | ZC3HAV1 interactions | SPTBN1 TNIP1 DAXX MRPS22 PRRC2C NXF2 KIF14 USP48 FUBP3 RC3H2 WWP2 RNF2 EPHA2 RTCA EBAG9 RBM34 ALG13 | 2.17e-04 | 606 | 210 | 17 | int:ZC3HAV1 |
| Interaction | SUMO1 interactions | UIMC1 SP3 ZMYM2 DAXX MKI67 KIF14 RANBP2 PHC1 AKAP9 PSIP1 PCNA | 2.22e-04 | 287 | 210 | 11 | int:SUMO1 |
| Interaction | HSPA2 interactions | IRF2BP2 MCM5 TNIP1 RRBP1 NEK4 PRRC2C HSPA6 ZNF703 POU2F1 PHC1 CHD5 TLN1 PALLD TEDC1 | 2.24e-04 | 440 | 210 | 14 | int:HSPA2 |
| Interaction | EZR interactions | TNIP1 SEPTIN6 ADORA2B EIF2S2 KIF14 KIF5C USP48 IPO5 ANK2 ZDHHC5 ARHGEF12 PPP6R1 EPHA2 MACF1 PALLD EPB41 | 2.36e-04 | 553 | 210 | 16 | int:EZR |
| Interaction | USP10 interactions | SPTBN1 TNIP1 FASN EIF2S2 KIF14 RC3H2 CPSF6 WWP2 PPP6R1 RUVBL1 PCNA | 2.43e-04 | 290 | 210 | 11 | int:USP10 |
| Interaction | CIT interactions | IMPDH2 SPTBN1 MCM4 MCM5 PFAS ADGRV1 MDH2 TRIP12 ITIH4 BPTF FASN PIK3CG PRRC2C EIF2S2 MKI67 KIF14 BOD1L1 HSPA6 SDHA WWC1 IPO5 RANBP2 SUN1 MED1 EDA AKAP9 RUVBL1 PSIP1 MACF1 ATIC | 2.43e-04 | 1450 | 210 | 30 | int:CIT |
| Interaction | HAO2 interactions | 2.54e-04 | 30 | 210 | 4 | int:HAO2 | |
| Interaction | KIF5B interactions | MCMBP IMPDH2 TNIP1 DAXX RRBP1 NFKB1 KIF14 KIF5C USP48 IPO5 RANBP2 CPSF6 | 3.06e-04 | 348 | 210 | 12 | int:KIF5B |
| Interaction | SAMD1 interactions | 3.09e-04 | 123 | 210 | 7 | int:SAMD1 | |
| Interaction | PML interactions | UIMC1 IRF2BP2 SP1 SP3 ERCC4 ZMYM2 DAXX RRBP1 NEK4 FASN NFKB1 KIF14 HSPA6 IPO5 RANBP2 SMC6 MED1 RBM12 OXCT1 TLN1 PALLD PCNA | 3.09e-04 | 933 | 210 | 22 | int:PML |
| Interaction | AGR2 interactions | IMPDH2 SPTBN1 COG3 RRBP1 MDH2 SEPTIN6 FASN EIF2S2 GPSM2 IQGAP3 IPO5 CPSF6 CAMLG AKAP9 RUVBL1 PSIP1 CD34 TLN1 MACF1 ATIC MYO16 ALG13 | 3.14e-04 | 934 | 210 | 22 | int:AGR2 |
| Interaction | EPB41L2 interactions | GPATCH8 TRIP12 BPTF KIF14 USP48 HSPA6 WWC1 RANBP2 EPHA2 TLN1 EBAG9 | 3.16e-04 | 299 | 210 | 11 | int:EPB41L2 |
| Interaction | ABCB1 interactions | 3.16e-04 | 57 | 210 | 5 | int:ABCB1 | |
| Interaction | TENM3 interactions | 3.16e-04 | 57 | 210 | 5 | int:TENM3 | |
| Interaction | ACTC1 interactions | IRF2BP2 SP1 SPTBN1 TNIP1 MARCKSL1 MDH2 NEK4 FASN MKI67 KIF14 BOD1L1 USP48 CPSF6 MED1 RUVBL1 ARID2 TLN1 PCNA | 3.66e-04 | 694 | 210 | 18 | int:ACTC1 |
| Interaction | TOP1MT interactions | 3.70e-04 | 33 | 210 | 4 | int:TOP1MT | |
| Interaction | DCTN2 interactions | MCM4 MARCKSL1 COG3 ZNF518A NEK4 PEX5 USP48 ARHGEF12 PPP6R1 AKAP9 RUVBL1 TEDC1 | 3.76e-04 | 356 | 210 | 12 | int:DCTN2 |
| Interaction | HELZ interactions | 3.80e-04 | 257 | 210 | 10 | int:HELZ | |
| Interaction | TPI1 interactions | SP1 MDH2 SERPINB5 HINT2 USP48 SDHA PRRT2 OXCT1 RNF2 SHARPIN PCNA | 3.95e-04 | 307 | 210 | 11 | int:TPI1 |
| Interaction | AURKB interactions | IMPDH2 TNIP1 ADGRV1 AURKC FASN PRRC2C NFKB1 MKI67 KIF14 USP48 SDHA RC3H2 RANBP2 RNF2 RUVBL1 MYO1F SHARPIN MACF1 CDC27 | 4.03e-04 | 761 | 210 | 19 | int:AURKB |
| Interaction | FKBP5 interactions | MCMBP MCM4 MCM5 URB2 PLEKHH1 NEK4 AURKC FASN PRRC2C IPO5 RUVBL1 PALLD TEDC1 | 4.24e-04 | 414 | 210 | 13 | int:FKBP5 |
| Interaction | MDC1 interactions | UIMC1 ERCC4 IMPDH2 TNIP1 TRIP12 NEK4 MKI67 KIF14 BOD1L1 CPSF6 SMC6 PHC1 CDC27 | 4.24e-04 | 414 | 210 | 13 | int:MDC1 |
| Interaction | CDH1 interactions | UIMC1 SPTBN1 ITGA6 SBSN FASN CGN PKD1 MKI67 ZDHHC5 ARHGEF12 RNF2 RUVBL1 TENM3 EPHA2 TLN1 MACF1 ATIC CDC27 EPB41 | 4.50e-04 | 768 | 210 | 19 | int:CDH1 |
| Interaction | ILF3 interactions | MCM5 TNIP1 URB2 RRBP1 TRIP12 PDCD4 NEK4 FASN PRRC2C EIF2S2 KIF14 ZNF770 KIF5C USP48 RC3H2 CPSF6 WWP2 RNF2 UNC45B CDC27 RBM34 | 4.61e-04 | 896 | 210 | 21 | int:ILF3 |
| Interaction | SCN11A interactions | 4.63e-04 | 15 | 210 | 3 | int:SCN11A | |
| Interaction | HSPB1 interactions | SP1 GRIPAP1 SPTBN1 TNIP1 DAXX MDH2 AURKC NRXN1 PRRC2C KIF14 SDHA RC3H2 WWP2 OXCT1 RUVBL1 EPHA2 ATIC PALLD | 4.63e-04 | 708 | 210 | 18 | int:HSPB1 |
| Interaction | LONP2 interactions | 4.68e-04 | 62 | 210 | 5 | int:LONP2 | |
| Interaction | SP1 interactions | SP1 SP3 SP4 MIS18BP1 ABCB1 FASN NFKB1 MKI67 POU2F1 TBL1XR1 PSIP1 TLN1 | 4.70e-04 | 365 | 210 | 12 | int:SP1 |
| Interaction | G3BP1 interactions | UIMC1 MCMBP IMPDH2 MCM4 MCM5 TNIP1 PRRC2C EIF2S2 MKI67 KIF14 FUBP3 RC3H2 RANBP2 CPSF6 WWP2 SUN1 RNF2 MACF1 PALLD PCNA | 4.80e-04 | 835 | 210 | 20 | int:G3BP1 |
| Interaction | ASH2L interactions | 4.83e-04 | 265 | 210 | 10 | int:ASH2L | |
| Interaction | MCM5 interactions | MCMBP SPTBN1 MCM4 MCM5 TNIP1 SBSN NEK4 MKI67 KIF14 USP48 HSPA6 SDHA RNF2 | 4.86e-04 | 420 | 210 | 13 | int:MCM5 |
| Interaction | U2AF2 interactions | IMPDH2 TNIP1 GPATCH8 MDH2 MKI67 KIF14 FUBP3 IPO5 RC3H2 CPSF6 WWP2 RNF2 RUVBL1 TLN1 ATIC EPB41 PCNA | 4.94e-04 | 651 | 210 | 17 | int:U2AF2 |
| Interaction | H2AX interactions | UIMC1 ZMYM2 MCM4 MCM5 GPATCH8 NEK4 BPTF EIF2S2 MKI67 KIF14 USP48 RANBP2 RNF2 RUVBL1 PSIP1 BAZ2A | 5.09e-04 | 593 | 210 | 16 | int:H2AX |
| Interaction | WDR5 interactions | SP1 IMPDH2 SPTBN1 ZMYM2 MARCKSL1 RRBP1 FASN PRRC2C EIF2S2 BOD1L1 FUBP3 SDHA IPO5 RANBP2 CPSF6 WWP2 THBS1 RNF2 RUVBL1 PSIP1 TLN1 MACF1 CDC27 RBM34 | 5.13e-04 | 1101 | 210 | 24 | int:WDR5 |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.12e-06 | 115 | 140 | 8 | 769 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 3.69e-05 | 9 | 140 | 3 | 755 | |
| GeneFamily | ATP binding cassette subfamily B | 7.16e-05 | 11 | 140 | 3 | 806 | |
| GeneFamily | C2 and WW domain containing | 3.54e-04 | 4 | 140 | 2 | 838 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 4.37e-04 | 46 | 140 | 4 | 622 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.27e-04 | 181 | 140 | 7 | 694 | |
| GeneFamily | MCM family | 2.07e-03 | 9 | 140 | 2 | 1085 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | KIF21B SP1 BPTF FASN ATP8A1 PIK3CG PRRC2C ATAD2B KIF14 ARAP2 BAZ2A TLN1 MACF1 NFAT5 | 2.62e-10 | 180 | 212 | 14 | M8239 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SP3 ZMYM2 ITGA6 GBE1 GPATCH8 TRIP12 NEK4 ADORA2B BPTF PRRC2C NFKB1 ATAD2B KIF14 KIF5C WWC1 ARAP2 RANBP2 APBB2 MED1 ZDHHC17 RNF2 AKAP9 MICAL2 MACF1 BICRAL CDC27 TMCC1 | 1.73e-09 | 856 | 212 | 27 | M4500 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | KIF21B SP3 MCMBP MIS18BP1 DAXX GPATCH8 RSRC2 TRIP12 DCAF5 PDCD4 SEPTIN6 ABCB1 NXPE3 BPTF ATP8A1 BOD1L1 ARAP2 RANBP2 AGGF1 PPP6R1 MED1 TBL1XR1 RBM12 AKAP9 PSIP1 ARID2 DHRS7 TLN1 MYO1F MACF1 PRKCH NFAT5 MTMR9 | 1.42e-07 | 1492 | 212 | 33 | M40023 |
| Coexpression | GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_UP | KIF21B SPTBN1 ITGA6 PDCD4 SEPTIN6 FASN PHC1 OXCT1 PSIP1 PRKCH ATIC | 7.27e-07 | 199 | 212 | 11 | M3087 |
| Coexpression | DOANE_RESPONSE_TO_ANDROGEN_DN | MCM4 MCM5 PRRC2C ATAD2B PEX5 KIF5C PHC1 THBS1 AKAP9 PSIP1 PALLD | 4.86e-06 | 242 | 212 | 11 | M12816 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 6.52e-06 | 33 | 212 | 5 | MM477 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | RGPD4 SPTBN1 RGPD1 ZMYM2 SEPTIN6 NOMO2 ATAD2B USP48 RGPD2 RANBP2 MED1 PSIP1 ARID2 NOMO3 RBM34 | 8.14e-06 | 474 | 212 | 15 | M40991 |
| Coexpression | RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN | IMPDH2 GBE1 MCM4 MCM5 MARCKSL1 NEK4 OXCT1 PSIP1 CD34 RTCA PRKCH ATIC PCNA | 1.04e-05 | 368 | 212 | 13 | M1859 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | PRTG IMPDH2 ITGA6 PDCD4 ABCB1 FASN PRRC2C HINT2 AKAP6 PHC1 ZNF17 ZNF827 MICAL2 ABCB11 PCP4L1 PRKCH | 1.95e-05 | 574 | 212 | 16 | M8215 |
| Coexpression | NUYTTEN_EZH2_TARGETS_DN | IRF2BP2 SP3 MCMBP MIS18BP1 IMPDH1 IMPDH2 ZMYM2 ITGA6 MCM4 ASB9 KIF14 FUBP3 IQGAP3 IPO5 ZDHHC17 TBL1XR1 PHC1 RBM12 MICAL2 EPHA2 ALG13 TEDC1 | 3.14e-05 | 1023 | 212 | 22 | M17122 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | SP1 PRTG SPTBN1 ZMYM2 RRBP1 PDCD4 ZNF518A PLEKHH1 NEK4 ATP8A1 WWC1 APBB2 GUSBP1 TBL1XR1 THBS1 AKAP9 ARID2 BICRAL EPB41 | 3.36e-05 | 807 | 212 | 19 | M16651 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | SP3 ADORA2B BPTF NFKB1 MKI67 KIF14 WWC1 AKAP9 MICAL2 BICRAL TMCC1 | 3.60e-05 | 300 | 212 | 11 | M8702 |
| Coexpression | GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_UP | 3.73e-05 | 199 | 212 | 9 | M5599 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_DN | 3.88e-05 | 200 | 212 | 9 | M9925 | |
| Coexpression | GSE17721_0.5H_VS_12H_CPG_BMDC_UP | 3.88e-05 | 200 | 212 | 9 | M4119 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 3.94e-05 | 250 | 212 | 10 | M11318 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | MCM4 MCM5 PFAS URB2 PIK3CG PRRC2C EIF2S2 MKI67 KIF14 IPO5 CPSF6 RNF2 RUVBL1 PSIP1 ATIC EPB41 RBM34 PCNA | 5.12e-05 | 761 | 212 | 18 | M11961 |
| Coexpression | GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 6.21e-05 | 165 | 212 | 8 | M9105 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_UP | 6.32e-05 | 213 | 212 | 9 | M14601 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | ABCC4 GBE1 MARCKSL1 MDH2 TRIP12 PDCD4 CNOT8 ADORA2B FASN PLAA NFKB1 EIF2S2 IPO5 HSPG2 RANBP2 CPSF6 CAMLG PHC1 OXCT1 RUVBL1 PSIP1 RTCA EBAG9 ATIC CDC27 EPB41 | 6.87e-05 | 1399 | 212 | 26 | M535 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | SPTBN1 ITGA6 MCM4 FASN ASB9 PRRC2C KIF14 USP48 SDHA ANK2 OXCT1 AKAP9 GUSB MACF1 EBAG9 CDC27 PCNA ALG13 | 8.24e-05 | 790 | 212 | 18 | M12490 |
| Coexpression | MULLIGHAN_MLL_SIGNATURE_2_DN | ABCC4 SLC24A3 MRPS22 PDCD4 ABCB1 ARAP2 RANBP2 CD34 MACF1 PRKCH | 9.83e-05 | 279 | 212 | 10 | M16867 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | PRTG IMPDH2 ITGA6 PDCD4 ABCB1 FASN PRRC2C HINT2 AKAP6 PHC1 ZNF827 MICAL2 ABCB11 PCP4L1 PRKCH | 1.20e-04 | 600 | 212 | 15 | MM1025 |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1 | MIS18BP1 IMPDH2 SLC24A3 MCM4 DAXX PDCD4 IQGAP3 IPO5 ZNF703 APBB2 ARID2 DHRS7 ATIC PALLD | 1.24e-04 | 534 | 212 | 14 | M12522 |
| Coexpression | FISCHER_DREAM_TARGETS | SP1 SP4 MIS18BP1 E2F7 MCM4 MCM5 PFAS ZNF518A MKI67 KIF14 GPSM2 IQGAP3 SMC6 POU2F1 RNF2 PSIP1 ARID2 EBAG9 PCNA TEDC1 | 1.27e-04 | 969 | 212 | 20 | M149 |
| Coexpression | GARY_CD5_TARGETS_UP | KIF21B IRF2BP2 ZMYM2 GBE1 PDCD4 SEPTIN6 FASN CAMLG ZDHHC5 APBB2 DHRS7 TLN1 NFAT5 | 1.37e-04 | 473 | 212 | 13 | M17693 |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | 1.42e-04 | 237 | 212 | 9 | M15606 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | 1.56e-04 | 240 | 212 | 9 | MM976 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | MIS18BP1 ITGA6 GBE1 MCM4 MCM5 MRPS22 ADORA2B MKI67 IQGAP3 NPNT IPO5 THBS1 EPHA2 PCNA | 1.68e-04 | 550 | 212 | 14 | M16189 |
| Coexpression | OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_DN | 1.72e-04 | 243 | 212 | 9 | M41178 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | MCMBP MIS18BP1 E2F7 MCM4 MCM5 MKI67 KIF14 USP48 SMC6 POU2F1 OXCT1 GUSB CDC27 PCNA PHTF1 TEDC1 | 1.80e-04 | 694 | 212 | 16 | M45767 |
| Coexpression | MENON_FETAL_KIDNEY_9_ENDOTHELIAL_CELLS | 1.84e-04 | 102 | 212 | 6 | M39259 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | IRF2BP2 SPTBN1 MELTF SERPINB5 NFKB1 CGN WWC1 ZNF703 CPSF6 SUN1 AGGF1 TBL1XR1 THBS1 EPHA2 ARID2 TLN1 PRKCH TEDC1 | 1.84e-04 | 843 | 212 | 18 | M2356 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | RGPD4 SP1 MCMBP RGPD1 COG3 RSRC2 TRIP12 DCAF5 PLAA EIF2S2 USP48 FUBP3 IPO5 RGPD2 RC3H2 RANBP2 AGGF1 PPP6R1 TBL1XR1 RUVBL1 SHARPIN EBAG9 | 1.89e-04 | 1158 | 212 | 22 | MM1338 |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_2H_UP | 2.12e-04 | 197 | 212 | 8 | M8752 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN | 2.12e-04 | 197 | 212 | 8 | M5210 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_DN | 2.19e-04 | 198 | 212 | 8 | M4441 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | MIS18BP1 E2F7 ITGA6 GPSM2 ZNF770 ARAP2 CPSF6 KIF16B ZNF17 OXCT1 AKAP9 ALG13 | 2.33e-04 | 434 | 212 | 12 | M15150 |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 2.35e-04 | 200 | 212 | 8 | M9439 | |
| Coexpression | GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_UP | 2.35e-04 | 200 | 212 | 8 | M9380 | |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_DN | 2.35e-04 | 200 | 212 | 8 | M7441 | |
| Coexpression | GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP | 2.35e-04 | 200 | 212 | 8 | M5185 | |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP | 2.35e-04 | 200 | 212 | 8 | M5261 | |
| Coexpression | GSE7852_LN_VS_THYMUS_TREG_UP | 2.35e-04 | 200 | 212 | 8 | M5737 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | MCMBP MIS18BP1 E2F7 ITGA6 MCM4 MCM5 NXPE3 MKI67 KIF14 IPO5 SMC6 TBL1XR1 PHC1 OXCT1 GUSB ARID2 CDC27 PCNA TEDC1 | 2.41e-04 | 939 | 212 | 19 | M45768 |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | MIS18BP1 ITGA6 GBE1 MCM4 MCM5 MRPS22 ADORA2B MKI67 IQGAP3 NPNT IPO5 THBS1 EPHA2 PCNA | 2.47e-04 | 571 | 212 | 14 | MM1100 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | MCMBP IMPDH1 MCM4 EIF2S2 MKI67 KIF14 GPSM2 IQGAP3 SMC6 AGGF1 MICAL2 RTCA ATIC PCNA PHTF1 | 2.58e-04 | 644 | 212 | 15 | M10501 |
| Coexpression | LE_EGR2_TARGETS_UP | 2.64e-04 | 109 | 212 | 6 | MM1148 | |
| Coexpression | LE_EGR2_TARGETS_UP | 2.78e-04 | 110 | 212 | 6 | M12804 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_CIRCRNA_GENES | 3.03e-04 | 40 | 212 | 4 | MM17488 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | SP4 MIS18BP1 E2F7 ZMYM2 MCM4 RSRC2 MRPS22 BPTF FASN YAE1 ATAD2B EIF2S2 MKI67 GPSM2 ZNF770 BOD1L1 ANK2 CPSF6 SMC6 POU2F1 PHC1 OXCT1 RNF2 AKAP9 PSIP1 RPUSD2 MACF1 EBAG9 CDC27 EPB41 PCNA | 1.76e-06 | 1257 | 207 | 31 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | SP4 MIS18BP1 E2F7 ZMYM2 MCM4 ADGRV1 RSRC2 MRPS22 BPTF FASN YAE1 ATAD2B EIF2S2 MKI67 GPSM2 ZNF770 BOD1L1 KIF5C ANK2 CPSF6 SMC6 POU2F1 PHC1 OXCT1 RNF2 AKAP9 PSIP1 RPUSD2 MACF1 EBAG9 CDC27 EPB41 PCNA | 5.07e-06 | 1459 | 207 | 33 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | ZMYM2 ZNF518A NEK4 ATAD2B EIF2S2 MKI67 BOD1L1 KIF5C RANBP2 SMC6 POU2F1 OXCT1 AKAP9 | 1.23e-05 | 311 | 207 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | SP3 MIS18BP1 E2F7 ZMYM2 FOXA2 NEK4 FASN NRXN1 ATAD2B EIF2S2 MKI67 KIF14 GPSM2 BOD1L1 CUX2 ANK2 CPSF6 SMC6 PHC1 AKAP9 PSIP1 RPUSD2 MACF1 EBAG9 EPB41 PHTF1 | 1.44e-05 | 1060 | 207 | 26 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | KIF21B SP4 MIS18BP1 E2F7 ZMYM2 GBE1 ADGRV1 GPATCH8 BPTF NRXN1 YAE1 EIF2S2 MKI67 KIF14 GPSM2 BOD1L1 KIF5C RC3H2 CUX2 ANK2 CPSF6 SMC6 PHC1 RBM12 AKAP9 PSIP1 RPUSD2 EBAG9 EPB41 PHTF1 | 2.66e-05 | 1370 | 207 | 30 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | SP3 MIS18BP1 E2F7 ZMYM2 ADGRV1 FOXA2 ABCB1 NEK4 FASN NRXN1 ATAD2B CGN EIF2S2 MKI67 KIF14 GPSM2 BOD1L1 KIF5C CUX2 ANK2 CPSF6 SMC6 PHC1 AKAP9 PSIP1 RPUSD2 MACF1 EBAG9 EPB41 PHTF1 | 4.77e-05 | 1414 | 207 | 30 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | SP3 MIS18BP1 E2F7 TNIP1 RSRC2 ZNF518A PRRC2C EIF2S2 RANBP2 POU2F1 PHC1 RNF2 AKAP9 EBAG9 EPB41 | 6.05e-05 | 469 | 207 | 15 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#3_top-relative-expression-ranked_200 | 9.22e-05 | 47 | 207 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k3 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | SP1 SP3 ZNF155 ZNF770 BOD1L1 TET3 KIF16B ARHGEF12 MED1 ARID2 NFAT5 | 1.63e-09 | 186 | 212 | 11 | 03db813598b67b1e08f759758a1c2023396921fa |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | ABCC4 MCM4 SLC10A7 ATP8A1 NOMO2 KIF14 SUN1 ARID2 MACF1 NFAT5 | 2.27e-08 | 186 | 212 | 10 | 8571956890fc9894d766ba294a28e376b4aba428 |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-08 | 194 | 212 | 10 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.29e-08 | 199 | 212 | 10 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | IRF2BP2 MIS18BP1 TRIP12 BPTF FHAD1 PRRC2C BOD1L1 AKAP9 EPHA2 CDC27 | 4.29e-08 | 199 | 212 | 10 | 61b1ed2db71b96157b92b7535d1955a4033098da |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | RSRC2 TRIP12 BPTF PRRC2C ATAD2B BOD1L1 ARAP2 AKAP9 MACF1 EPB41 | 4.50e-08 | 200 | 212 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.46e-08 | 159 | 212 | 9 | f7bccfeffa737f151417bf52ea45111b0957bce9 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.71e-07 | 185 | 212 | 9 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-07 | 188 | 212 | 9 | d577b3c2a844e3062c7ca9e9ebc1722d0ac95caa | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-07 | 188 | 212 | 9 | 1e788b60dd643bf220d8dfafa82d85fd083cbc71 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-07 | 188 | 212 | 9 | 4dc89c7843ebd078e3414e835c56f11fa27f0c5f | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-07 | 190 | 212 | 9 | 52c59001a079c76249abbaa3141e9e661b83d9a0 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.55e-07 | 191 | 212 | 9 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.60e-07 | 197 | 212 | 9 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.01e-07 | 199 | 212 | 9 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 5.01e-07 | 199 | 212 | 9 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 5.01e-07 | 199 | 212 | 9 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.22e-07 | 200 | 212 | 9 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-06 | 163 | 212 | 8 | aa5ea367f787c1543afb7eb80a801432e1c44011 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.55e-06 | 169 | 212 | 8 | 16c52a0f6d96ecc1832922fce9b39691849f0d73 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel|Adult / Lineage, Cell type, age group and donor | 1.77e-06 | 172 | 212 | 8 | ad4ffdb3fc0c560a9cbaa2bc048476cbc43e8fd6 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 178 | 212 | 8 | 8aef208b6351143562c87715bb11628880abce94 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.29e-06 | 178 | 212 | 8 | ea10117026021c959ffc871fc377cdb3e161d264 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-06 | 182 | 212 | 8 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-06 | 182 | 212 | 8 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.81e-06 | 183 | 212 | 8 | 29b62dd542bc3f8df843998f577724f3818d4271 | |
| ToppCell | facs-Heart-LV-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-06 | 188 | 212 | 8 | e5a8ca4613ab0bf1584b9e78959adf41d0bf379f | |
| ToppCell | facs-Heart-LV-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-06 | 188 | 212 | 8 | 0fc3a6562e6895f6fe7a93397eae842a75c60c93 | |
| ToppCell | facs-Heart-LV-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-06 | 188 | 212 | 8 | ed11e26ff4ef3d6314b5f5734062519b9aa285c1 | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 3.43e-06 | 188 | 212 | 8 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.71e-06 | 190 | 212 | 8 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 3.86e-06 | 191 | 212 | 8 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-06 | 192 | 212 | 8 | 9d53b42cdb537b30233cdfdc08052c8b13a1113f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-06 | 192 | 212 | 8 | 042391162df2e3d0027688dd14163c4c6821afe0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-06 | 192 | 212 | 8 | 9ae05db5bfb8b9d3935c0328e6f2d489d2b1ebfd | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-06 | 192 | 212 | 8 | 71b0bfee0461ff64cef35881db3959c517e9731b | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-06 | 192 | 212 | 8 | a116db7dec495e5a0ba9c7537057cd1e567d7885 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-06 | 192 | 212 | 8 | 66defad13bd8e79319741e43ddb056841710b1d7 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.16e-06 | 193 | 212 | 8 | f25bdd10ef531b8d8441ea84573078b4b1b0f105 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.16e-06 | 193 | 212 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.16e-06 | 193 | 212 | 8 | 097a244cf37ce6c1ace9bae56beb7de59442cd6b | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-06 | 194 | 212 | 8 | effd38e51062b225ecabc7e1c50154e65495d559 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.33e-06 | 194 | 212 | 8 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.33e-06 | 194 | 212 | 8 | c6cee7d15af76f9a60d7f414ef0bcc1735c47b7a | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.49e-06 | 195 | 212 | 8 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.49e-06 | 195 | 212 | 8 | 9ad4981c4d157edc752de206ab0d754aa14beab8 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-06 | 195 | 212 | 8 | b57132802cb977551e214880984f3edcd375474f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.66e-06 | 196 | 212 | 8 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.66e-06 | 196 | 212 | 8 | 629236f95c838a473b5964a49b7c1b7ad863ea12 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.84e-06 | 197 | 212 | 8 | 491e12a5fca06b86443c0173f5fa750ea3b8a715 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 4.84e-06 | 197 | 212 | 8 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.84e-06 | 197 | 212 | 8 | 2430f31d9312338e0ca23bfc6bdb0365340860fd | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.84e-06 | 197 | 212 | 8 | b18f2c14d6720f6ae8520c0800356f4a57393ad3 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.84e-06 | 197 | 212 | 8 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.03e-06 | 198 | 212 | 8 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Immune_cells-large_pre-B.|Immune_cells / Lineage and Cell class | 5.03e-06 | 198 | 212 | 8 | bc9ceefadb153907d2854d1f736d17349003cb31 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.22e-06 | 199 | 212 | 8 | 6a89c3a65fa50af92585c52bec203bcff6f94efc | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2_proliferating-AT2_proliferating_L.0.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.22e-06 | 199 | 212 | 8 | d7dbc551c05da32c698908348572fb0ce1166e10 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.22e-06 | 199 | 212 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.22e-06 | 199 | 212 | 8 | dadee9fc6ce4f4bdb19d29326889316443dda0cb | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.41e-06 | 200 | 212 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.41e-06 | 200 | 212 | 8 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.41e-06 | 200 | 212 | 8 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| ToppCell | 356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.41e-06 | 200 | 212 | 8 | 2afbb5b5742b956993796621fea7e0c9888754a1 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 5.41e-06 | 200 | 212 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.41e-06 | 200 | 212 | 8 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 5.41e-06 | 200 | 212 | 8 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.41e-06 | 200 | 212 | 8 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.41e-06 | 200 | 212 | 8 | 4462ebd5d4632788f10a93fadd2babae701c754f | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.23e-05 | 161 | 212 | 7 | 0dd1401b4c990d49fccb702a9f9867590a58e203 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.23e-05 | 161 | 212 | 7 | b6a31c033edc74f23a20aab1f18e80cc83ffee4c | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.23e-05 | 161 | 212 | 7 | efb811dda4d73107983a5f68302bdcf4f408d5b4 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.23e-05 | 161 | 212 | 7 | 28d5dbd20c9f8e0069f172d552997a044790e1a7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 162 | 212 | 7 | 5428c9fdb816f564395ebb4520448e5f3a42b025 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.34e-05 | 163 | 212 | 7 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epi_progenitor|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.69e-05 | 169 | 212 | 7 | 1a47a4892a5e6a69555f5332308503526e5422a7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-05 | 171 | 212 | 7 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-05 | 171 | 212 | 7 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-CD45____plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 173 | 212 | 7 | 60e427f6c7d953cef5f692043670ff0b49cdce72 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-05 | 174 | 212 | 7 | 66555c610251ea04f968c258e312d720c18e7cde | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 2.11e-05 | 175 | 212 | 7 | bde785ff0c854646d7ab8571359e9d69a7bf013f | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.11e-05 | 175 | 212 | 7 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-05 | 177 | 212 | 7 | 4f88ea4cfcfa8a9af5a14ab6f6be3b2aa015852e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-05 | 178 | 212 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.36e-05 | 178 | 212 | 7 | a62137d7f5fac16619f8a02844cdb0be7a794bf2 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.44e-05 | 179 | 212 | 7 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.53e-05 | 180 | 212 | 7 | 97e0dcb7cfbba60a782824c5e23995058609fcd4 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 2.62e-05 | 181 | 212 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | facs-Pancreas-Exocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-05 | 183 | 212 | 7 | 92eee4bdd84965ae0bd1ed1c7f26a3b83ad0cdac | |
| ToppCell | facs-Pancreas-Exocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-05 | 183 | 212 | 7 | c9d9d7dd629ce6787502103b158a07e8684a66f8 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-05 | 183 | 212 | 7 | c7ef8ee2b3fcfa69cea0fdcb2041674b832933db | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-05 | 183 | 212 | 7 | 42dc31d587fbb9724b2f0be5ee8ed77233f67b86 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.87e-05 | 124 | 212 | 6 | a7b7d8b14d1218194da8fcf69b4780b6e9469332 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-05 | 184 | 212 | 7 | fa38d6a8709f520a027ad7e3ff783c84187ec467 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.91e-05 | 184 | 212 | 7 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.91e-05 | 184 | 212 | 7 | 571136c832cb8c08457744152231537aa8e8abd7 | |
| ToppCell | (4)_Endothelial_cells-(40)_EC-arterial|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.91e-05 | 184 | 212 | 7 | 7e1a2971321ddcfa00d78d3e3ba7960e532f9392 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-05 | 184 | 212 | 7 | e7b9c69fc77040c5191ad8089697051e2589c30e | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.91e-05 | 184 | 212 | 7 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 186 | 212 | 7 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| Drug | thioinosinic acid | 4.93e-08 | 23 | 209 | 6 | CID003034391 | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | MIS18BP1 ZMYM2 GPATCH8 PRRC2C KIF5C IPO5 TBC1D30 APBB2 AGGF1 MED1 TENM3 CDC27 | 2.14e-07 | 191 | 209 | 12 | 6020_DN |
| Drug | yohimbine; Down 200; 22.9uM; MCF7; HT_HG-U133A_EA | MCM5 TNIP1 PDCD4 NEK4 BPTF PRRC2C ATAD2B RC3H2 PPP6R1 MICAL2 PRKCH TMCC1 | 2.68e-07 | 195 | 209 | 12 | 1119_DN |
| Drug | Forskolin, from Coleus forskohlii; Down 200; 0.5uM; PC3; HT_HG-U133A | MCM5 FOXA2 PDCD4 SEPTIN6 CNOT8 ATAD2B ZCWPW1 ARHGEF12 BAZ2A NFAT5 TMCC1 | 1.72e-06 | 192 | 209 | 11 | 7104_DN |
| Drug | Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A | SCN11A MCMBP MIS18BP1 ZMYM2 BBS9 AURKC PLAA APBB2 THBS1 TLN1 NFAT5 | 1.90e-06 | 194 | 209 | 11 | 4320_DN |
| Drug | Dyclonine hydrochloride [536-43-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | ITGA6 GPATCH8 RRBP1 PEX5 KIF5C IPO5 HSPG2 APBB2 EDA THBS1 RBM34 | 2.00e-06 | 195 | 209 | 11 | 7022_UP |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 3.11e-06 | 165 | 209 | 10 | 3851_UP | |
| Drug | naringine | 3.84e-06 | 46 | 209 | 6 | CID000004441 | |
| Drug | AC1Q6RZK | 1.02e-05 | 32 | 209 | 5 | CID000000153 | |
| Drug | Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | ERCC4 SPTBN1 ZMYM2 MCM4 TBC1D30 SUN1 ZDHHC17 THBS1 RNF2 NFAT5 | 1.08e-05 | 190 | 209 | 10 | 2869_DN |
| Drug | Chlorhexidine [55-56-1]; Up 200; 8uM; HL60; HG-U133A | RRBP1 PDCD4 SEPTIN6 PIK3CG ATAD2B APBB2 ARHGEF12 RNF2 CDC27 NFAT5 | 1.36e-05 | 195 | 209 | 10 | 2025_UP |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 10uM; PC3; HT_HG-U133A | 1.42e-05 | 196 | 209 | 10 | 4331_UP | |
| Drug | AC1NR4F4 | 1.49e-05 | 6 | 209 | 3 | CID005284420 | |
| Drug | HSR-903 | 1.49e-05 | 6 | 209 | 3 | CID000477670 | |
| Drug | AP1 metabolite | 1.49e-05 | 6 | 209 | 3 | CID000119377 | |
| Drug | atazanavir | 1.54e-05 | 120 | 209 | 8 | CID000148192 | |
| Drug | Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | SPTBN1 ZMYM2 RRBP1 PDCD4 KIF5C USP48 WWC1 ZDHHC17 MICAL2 PRKCH | 1.55e-05 | 198 | 209 | 10 | 4964_DN |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 1.55e-05 | 198 | 209 | 10 | 7003_DN | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 1.62e-05 | 199 | 209 | 10 | 7539_UP | |
| Drug | AC-759 | 1.68e-05 | 88 | 209 | 7 | CID000005396 | |
| Drug | Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; PC3; HT_HG-U133A | RRBP1 PLA2G15 PDCD4 SEPTIN6 CNOT8 NXPE3 APBB2 AGGF1 BICRAL PHTF1 | 1.69e-05 | 200 | 209 | 10 | 6333_DN |
| Drug | helenalin | 1.81e-05 | 89 | 209 | 7 | CID000023205 | |
| Drug | Ascorbic Acid | SP1 SP3 SP4 ERCC4 MCM4 PFAS FOXA2 ABCB1 NRXN1 NFKB1 ATAD2B EIF2S2 MKI67 SDHA SMC6 GUSB CD34 PCNA | 2.15e-05 | 628 | 209 | 18 | ctd:D001205 |
| Drug | Digoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 2.38e-05 | 166 | 209 | 9 | 5324_UP | |
| Drug | 2-(4-(biphenyl-4-sulfonyl)-piperazin-1-yl)-6,7-dipropoxyquinazolin-4-yl-amine | 2.60e-05 | 7 | 209 | 3 | ctd:C525921 | |
| Drug | isotetrandrine | 3.17e-05 | 97 | 209 | 7 | CID000005422 | |
| Drug | Methyl Parathion | 4.12e-05 | 69 | 209 | 6 | ctd:D008743 | |
| Drug | w 77 | 4.13e-05 | 8 | 209 | 3 | CID003086590 | |
| Drug | calcein AM | 4.13e-05 | 8 | 209 | 3 | ctd:C085925 | |
| Drug | tXMP | 4.13e-05 | 8 | 209 | 3 | CID003081384 | |
| Drug | temacrazine | 6.15e-05 | 9 | 209 | 3 | CID000472178 | |
| Drug | So324 | 6.15e-05 | 9 | 209 | 3 | CID000462261 | |
| Drug | indoxyl-beta-D-glucuronide | 6.15e-05 | 9 | 209 | 3 | CID002733785 | |
| Drug | NSC626779 | 6.27e-05 | 46 | 209 | 5 | CID000116733 | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 6.29e-05 | 188 | 209 | 9 | 6735_DN | |
| Drug | N-(2-hydroxypropyl)methacrylamide | 6.35e-05 | 24 | 209 | 4 | CID000038622 | |
| Drug | UC781 | 6.35e-05 | 24 | 209 | 4 | CID003000926 | |
| Drug | hyperoside | 6.35e-05 | 24 | 209 | 4 | ctd:C021304 | |
| Drug | Fast Blue BB | 6.35e-05 | 24 | 209 | 4 | CID000067108 | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A_EA | IMPDH1 ADORA2B RANBP2 TBC1D30 THBS1 RBM12 MICAL2 PALLD PHTF1 | 6.83e-05 | 190 | 209 | 9 | 1074_DN |
| Drug | Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 7.70e-05 | 193 | 209 | 9 | 7447_DN | |
| Drug | Thonzonium bromide [553-08-2]; Down 200; 6.8uM; PC3; HT_HG-U133A | 8.01e-05 | 194 | 209 | 9 | 4617_DN | |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 8.01e-05 | 194 | 209 | 9 | 7137_DN | |
| Drug | AC1N8H7N | 8.25e-05 | 78 | 209 | 6 | CID004318740 | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.33e-05 | 195 | 209 | 9 | 5213_DN | |
| Drug | Thiamphenicol [15318-45-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 8.33e-05 | 195 | 209 | 9 | 7033_UP | |
| Drug | mesochlorin e6 monoethylenediamine | 8.39e-05 | 2 | 209 | 2 | CID005488855 | |
| Drug | Proliferating Cell Nuclear Antigen | 8.39e-05 | 2 | 209 | 2 | ctd:D018809 | |
| Drug | hydroxymethylphosphonate | 8.39e-05 | 2 | 209 | 2 | CID000075795 | |
| Drug | 6-Chloropurine Riboside, 5'-Monophosphate | 8.39e-05 | 2 | 209 | 2 | DB03948 | |
| Drug | hexaethylphosphoramide | 8.39e-05 | 2 | 209 | 2 | CID000075805 | |
| Drug | taxuspine C | 8.39e-05 | 2 | 209 | 2 | CID005321745 | |
| Drug | 2,2-diphenyl-1,3-dioxolane | 8.39e-05 | 2 | 209 | 2 | CID000283230 | |
| Drug | Ro44-5912 | 8.39e-05 | 2 | 209 | 2 | CID000197370 | |
| Drug | Mycophenolate mofetil | 8.39e-05 | 2 | 209 | 2 | DB00688 | |
| Drug | 8-(3,3-dimethylallyl)chrysin | 8.39e-05 | 2 | 209 | 2 | CID005281903 | |
| Drug | AC1L8LCS | 8.39e-05 | 2 | 209 | 2 | CID000383419 | |
| Drug | sulfurmycin A | 8.39e-05 | 2 | 209 | 2 | CID000155836 | |
| Drug | purinogen | 8.39e-05 | 2 | 209 | 2 | CID003081226 | |
| Drug | DAPDOX | 8.39e-05 | 2 | 209 | 2 | CID000164413 | |
| Drug | AC1Q6JJG | 8.39e-05 | 2 | 209 | 2 | CID000164322 | |
| Drug | YM212 | 8.39e-05 | 2 | 209 | 2 | CID000129980 | |
| Drug | AC1L9X6T | 8.39e-05 | 2 | 209 | 2 | CID000477594 | |
| Drug | Ro11-2933 | 8.39e-05 | 2 | 209 | 2 | CID000115215 | |
| Drug | cnidiadin | 8.39e-05 | 2 | 209 | 2 | CID005315980 | |
| Drug | conferone | 8.39e-05 | 2 | 209 | 2 | CID001757335 | |
| Drug | Mycophenolic acid | 8.39e-05 | 2 | 209 | 2 | DB01024 | |
| Drug | VX-710-3 | 8.39e-05 | 2 | 209 | 2 | CID006450549 | |
| Drug | NAc-LLY-amide | 8.39e-05 | 2 | 209 | 2 | CID000443109 | |
| Drug | 62820-12-6 | 8.39e-05 | 2 | 209 | 2 | CID006449905 | |
| Drug | apropovir | 8.53e-05 | 49 | 209 | 5 | CID000064987 | |
| Drug | Triprolidine hydrochloride [550-70-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 8.67e-05 | 196 | 209 | 9 | 7408_UP | |
| Drug | Cetirizine dihydrochloride [83881-52-1]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 8.67e-05 | 196 | 209 | 9 | 2829_DN | |
| Drug | estriol glucuronide | 8.73e-05 | 10 | 209 | 3 | CID000152963 | |
| Drug | SP 0 | 8.73e-05 | 10 | 209 | 3 | CID002742752 | |
| Drug | AC1L1D3F | 8.86e-05 | 79 | 209 | 6 | CID000002177 | |
| Drug | Meticrane [1084-65-7]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 209 | 9 | 1671_DN | |
| Drug | Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; PC3; HT_HG-U133A | 9.01e-05 | 197 | 209 | 9 | 5811_DN | |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; PC3; HT_HG-U133A | 9.01e-05 | 197 | 209 | 9 | 4501_DN | |
| Drug | Ungerine nitrate; Down 200; 10.2uM; HL60; HT_HG-U133A | 9.01e-05 | 197 | 209 | 9 | 2514_DN | |
| Drug | Vitallium | 9.10e-05 | 244 | 209 | 10 | ctd:D014800 | |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 9.37e-05 | 198 | 209 | 9 | 4837_DN | |
| Drug | Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; MCF7; HT_HG-U133A | 9.37e-05 | 198 | 209 | 9 | 4158_UP | |
| Drug | Epirizole [18694-40-1]; Down 200; 17uM; MCF7; HT_HG-U133A | 9.37e-05 | 198 | 209 | 9 | 5995_DN | |
| Drug | Naringin hydrate [11032-30-7]; Down 200; 6.6uM; HL60; HT_HG-U133A | 9.37e-05 | 198 | 209 | 9 | 2425_DN | |
| Drug | Mecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; PC3; HT_HG-U133A | 9.73e-05 | 199 | 209 | 9 | 7263_DN | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; PC3; HT_HG-U133A | 9.73e-05 | 199 | 209 | 9 | 7298_UP | |
| Drug | pseudohypericin | 1.03e-04 | 27 | 209 | 4 | CID005281751 | |
| Drug | Thimerosal | KIF21B IRF2BP2 SP4 MIS18BP1 SPTBN1 GBE1 TNIP1 ADGRV1 COG3 MDH2 SLC10A7 FASN PRRC2C ATAD2B BOD1L1 TET3 HSPA6 ANK2 USP29 ARHGEF12 TBL1XR1 AKAP9 CDC27 NFAT5 ALG13 | 1.13e-04 | 1199 | 209 | 25 | ctd:D013849 |
| Drug | dithiane | 1.19e-04 | 11 | 209 | 3 | CID000136335 | |
| Drug | germacranolide | 1.19e-04 | 11 | 209 | 3 | CID000299917 | |
| Drug | AC1LCF1F | 1.25e-04 | 161 | 209 | 8 | CID000627275 | |
| Drug | Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.30e-04 | 162 | 209 | 8 | 7340_UP | |
| Drug | fluo-3 | 1.36e-04 | 122 | 209 | 7 | CID000104978 | |
| Drug | SC-19220 | 1.37e-04 | 29 | 209 | 4 | CID004336830 | |
| Drug | AC1L9E0Q | 1.57e-04 | 30 | 209 | 4 | CID000443095 | |
| Drug | 6-thioxanthine | 1.58e-04 | 12 | 209 | 3 | CID001268107 | |
| Drug | 5-Erfic | 1.58e-04 | 12 | 209 | 3 | CID000122653 | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 1.60e-04 | 167 | 209 | 8 | 6047_UP | |
| Drug | Digitoxigenin [143-62-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.60e-04 | 167 | 209 | 8 | 4801_UP | |
| Disease | cystic fibrosis (implicated_via_orthology) | 3.00e-07 | 9 | 209 | 4 | DOID:1485 (implicated_via_orthology) | |
| Disease | alkaline phosphatase measurement | IRF2BP2 SPTBN1 TNIP1 RRBP1 PLEKHM1 ITIH4 PKD1 USP48 FUBP3 HSPG2 CUX2 WWP2 KIF16B RNF2 ZNF827 GUSB ABCB11 MACF1 NFAT5 M6PR PHTF1 | 1.22e-05 | 1015 | 209 | 21 | EFO_0004533 |
| Disease | Malignant neoplasm of breast | TNIP1 COG3 MRPS22 PDCD4 ABCB1 FASN SERPINB5 EIF2S2 MKI67 BOD1L1 AKAP6 ANK2 SMC6 KIF16B POU2F1 THBS1 AKAP9 UNC45B CHD5 MACF1 CDC27 | 2.80e-05 | 1074 | 209 | 21 | C0006142 |
| Disease | PR interval | SPTBN1 CHRM2 ZNF469 SERPINB5 AKAP6 HSPG2 ABCB5 SUN1 THBS1 MICAL2 ARID2 OTUD7A MACF1 | 5.77e-05 | 495 | 209 | 13 | EFO_0004462 |
| Disease | pain | 8.30e-05 | 196 | 209 | 8 | EFO_0003843 | |
| Disease | Intellectual Disability | ZMYM2 BPTF FASN NRXN1 TET3 AKAP6 CACNA1B CUX2 PRRT2 MACF1 ATIC ALG13 | 9.06e-05 | 447 | 209 | 12 | C3714756 |
| Disease | cancer (implicated_via_orthology) | 1.34e-04 | 268 | 209 | 9 | DOID:162 (implicated_via_orthology) | |
| Disease | cortical thickness | IRF2BP2 SP1 PRTG SPTBN1 ADGRV1 BBS9 PLEKHM1 ZNF469 NFKB1 EIF2S2 PKD1 AKAP6 HSPG2 CPSF6 ARHGEF12 THBS1 SHARPIN MACF1 EBAG9 MYO16 | 1.38e-04 | 1113 | 209 | 20 | EFO_0004840 |
| Disease | NAD(P)H dehydrogenase [quinone] 1 measurement | 1.49e-04 | 3 | 209 | 2 | EFO_0803303 | |
| Disease | Nuclear non-senile cataract | 2.64e-04 | 18 | 209 | 3 | C1112705 | |
| Disease | Nuclear cataract | 2.64e-04 | 18 | 209 | 3 | C0392557 | |
| Disease | Abnormality of the nervous system | 2.97e-04 | 4 | 209 | 2 | HP_0000707 | |
| Disease | Autism Spectrum Disorders | 3.52e-04 | 85 | 209 | 5 | C1510586 | |
| Disease | mucositis (biomarker_via_orthology) | 4.92e-04 | 5 | 209 | 2 | DOID:0080178 (biomarker_via_orthology) | |
| Disease | alcohol consumption measurement | ERCC4 SPTBN1 GBE1 ADGRV1 CHRM2 NRXN1 DIO2 TET3 WWC1 ARAP2 AKAP6 EEF1AKMT4-ECE2 RC3H2 CUX2 MED1 AKAP9 ARID2 NFAT5 PHTF1 EMCN | 5.64e-04 | 1242 | 209 | 20 | EFO_0007878 |
| Disease | Peripheral Nervous System Diseases | 5.86e-04 | 54 | 209 | 4 | C4721453 | |
| Disease | extraversion | 7.35e-04 | 6 | 209 | 2 | EFO_0004317 | |
| Disease | Psychotic Disorders | 7.76e-04 | 101 | 209 | 5 | C0033975 | |
| Disease | mean corpuscular hemoglobin concentration | IRF2BP2 SP1 PFAS URB2 NEK4 SLC26A8 NFKB1 ATAD2B KIAA2012 CUX2 ZDHHC5 PPP6R1 TBL1XR1 SHARPIN ABCB11 MACF1 MYO16 EPB41 | 9.37e-04 | 1105 | 209 | 18 | EFO_0004528 |
| Disease | epilepsy (implicated_via_orthology) | 1.11e-03 | 163 | 209 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Movement Disorders | 1.12e-03 | 29 | 209 | 3 | C0026650 | |
| Disease | postherpetic neuralgia | 1.36e-03 | 8 | 209 | 2 | MONDO_0041052 | |
| Disease | Autistic behavior | 1.36e-03 | 8 | 209 | 2 | C0856975 | |
| Disease | leukodystrophy (implicated_via_orthology) | 1.74e-03 | 9 | 209 | 2 | DOID:10579 (implicated_via_orthology) | |
| Disease | egg allergy measurement | 1.74e-03 | 9 | 209 | 2 | EFO_0007018 | |
| Disease | facial morphology measurement | 1.90e-03 | 466 | 209 | 10 | EFO_0007841 | |
| Disease | coffee consumption measurement | 1.95e-03 | 182 | 209 | 6 | EFO_0006781 | |
| Disease | adult onset asthma, body mass index | 2.16e-03 | 10 | 209 | 2 | EFO_0004340, EFO_1002011 | |
| Disease | neuroticism measurement | SP4 ERCC4 GBE1 HPSE2 RSRC2 DCAF5 PLEKHM1 ITIH4 ATAD2B ZDHHC5 POM121L2 EDA TENM3 MICAL2 MTMR9 | 2.19e-03 | 909 | 209 | 15 | EFO_0007660 |
| Disease | pulse pressure measurement | TTC16 SLC24A3 GPATCH8 CHRM2 MELTF FASN ATAD2B PKD1 NPNT RC3H2 CUX2 ANK2 WWP2 ARHGEF12 PCDHA11 TBL1XR1 ZNF827 ABCB11 NFAT5 PALLD | 2.21e-03 | 1392 | 209 | 20 | EFO_0005763 |
| Disease | ovary epithelial cancer (is_implicated_in) | 2.63e-03 | 11 | 209 | 2 | DOID:2152 (is_implicated_in) | |
| Disease | memory performance | 2.69e-03 | 409 | 209 | 9 | EFO_0004874 | |
| Disease | platelet component distribution width | SCN11A DCAF5 MELTF PRRC2C ATAD2B NYAP1 PRUNE2 ZCWPW1 KIF16B BAZ2A TLN1 MACF1 EPB41 | 2.98e-03 | 755 | 209 | 13 | EFO_0007984 |
| Disease | thyroid gland carcinoma (is_marker_for) | 3.14e-03 | 12 | 209 | 2 | DOID:3963 (is_marker_for) | |
| Disease | thalamus volume | 3.17e-03 | 85 | 209 | 4 | EFO_0006935 | |
| Disease | vital capacity | TRIP12 PLEKHM1 MELTF ATAD2B KIAA2012 NPNT HSPG2 DSPP CAMLG WWP2 PCDHA11 POM121L2 MED1 THBS1 GUSB MYO1F NFAT5 MYO16 | 3.17e-03 | 1236 | 209 | 18 | EFO_0004312 |
| Disease | volumetric bone mineral density | 3.28e-03 | 42 | 209 | 3 | EFO_0007620 | |
| Disease | cortical surface area measurement | SP1 SP4 PRTG SPTBN1 RGPD1 ADGRV1 BBS9 PLEKHM1 ZNF469 PRRC2C NFKB1 ATAD2B PKD1 WWC1 CPSF6 ARHGEF12 THBS1 MACF1 MYO16 | 3.42e-03 | 1345 | 209 | 19 | EFO_0010736 |
| Disease | Common variable immunodeficiency | 3.70e-03 | 13 | 209 | 2 | cv:C0009447 | |
| Disease | alcohol and nicotine codependence | 3.70e-03 | 13 | 209 | 2 | EFO_0004776 | |
| Disease | Connective Tissue Diseases | 3.70e-03 | 13 | 209 | 2 | C0009782 | |
| Disease | Colorectal Neoplasms | 3.73e-03 | 277 | 209 | 7 | C0009404 | |
| Disease | diabetic retinopathy (biomarker_via_orthology) | 3.99e-03 | 45 | 209 | 3 | DOID:8947 (biomarker_via_orthology) | |
| Disease | neuroimaging measurement | KIF21B SP1 PRTG SPTBN1 RGPD1 BBS9 NEK4 ZNF469 PRRC2C PKD1 WWC1 ZDHHC5 ARHGEF12 THBS1 MACF1 MYO16 | 4.10e-03 | 1069 | 209 | 16 | EFO_0004346 |
| Disease | photoreceptor cell layer thickness measurement | 4.15e-03 | 148 | 209 | 5 | EFO_0803370 | |
| Disease | Neurodevelopmental Disorders | 4.37e-03 | 93 | 209 | 4 | C1535926 | |
| Disease | Colorectal Carcinoma | ABCC4 ZNF155 ABCB1 SERPINB5 MKI67 AKAP6 ANK2 ABCB5 EDA AKAP9 CHD5 ABCB11 | 4.52e-03 | 702 | 209 | 12 | C0009402 |
| Disease | Neoplasm Metastasis | 4.63e-03 | 217 | 209 | 6 | C0027627 | |
| Disease | Colonic Neoplasms | 4.64e-03 | 152 | 209 | 5 | C0009375 | |
| Disease | eosinophil count | SPTBN1 ITGA6 MCM4 TNIP1 RRBP1 ITIH4 ITPKA BPTF MELTF SERPINB5 NFKB1 KIAA2012 TET3 CUX2 WWP2 ABCB5 PHC1 AKAP9 SHARPIN MYO16 | 4.67e-03 | 1488 | 209 | 20 | EFO_0004842 |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | ERCC4 CDH23 GBE1 SLC24A3 ZNF518A BPTF NRXN1 TET3 ARAP2 AKAP6 CPSF6 BICRAL NFAT5 | 4.88e-03 | 801 | 209 | 13 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | Germ Cell Cancer | 4.93e-03 | 15 | 209 | 2 | C0740345 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 4.93e-03 | 15 | 209 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | Embryonal Neoplasm | 4.93e-03 | 15 | 209 | 2 | C0027654 | |
| Disease | Neoplasms, Germ Cell and Embryonal | 4.93e-03 | 15 | 209 | 2 | C0027658 | |
| Disease | Common Variable Immunodeficiency | 4.93e-03 | 15 | 209 | 2 | C0009447 | |
| Disease | Germ cell tumor | 4.93e-03 | 15 | 209 | 2 | C0205851 | |
| Disease | Neoplasms, Embryonal and Mixed | 4.93e-03 | 15 | 209 | 2 | C0205852 | |
| Disease | Cancer, Embryonal | 4.93e-03 | 15 | 209 | 2 | C0751364 | |
| Disease | Cancer, Embryonal and Mixed | 4.93e-03 | 15 | 209 | 2 | C0751365 | |
| Disease | cholestasis (biomarker_via_orthology) | 5.08e-03 | 49 | 209 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | aspartate aminotransferase measurement | KIF21B SP4 MCMBP HPSE2 RRBP1 PLEKHM1 ABCB1 KIAA2012 CUX2 SUN1 KIF16B ZNF827 BAZ2A ABCB11 | 5.31e-03 | 904 | 209 | 14 | EFO_0004736 |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 5.31e-03 | 157 | 209 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | Cardiomyopathy, Familial Idiopathic | 5.37e-03 | 50 | 209 | 3 | C1449563 | |
| Disease | hippocampal volume | 5.44e-03 | 297 | 209 | 7 | EFO_0005035 | |
| Disease | Malignant tumor of colon | 5.60e-03 | 159 | 209 | 5 | C0007102 | |
| Disease | Romano-Ward Syndrome | 5.61e-03 | 16 | 209 | 2 | C0035828 | |
| Disease | age at menopause | 5.94e-03 | 302 | 209 | 7 | EFO_0004704 | |
| Disease | Weight Gain | 6.05e-03 | 102 | 209 | 4 | C0043094 | |
| Disease | cyclic adenosine monophosphate measurement | 6.33e-03 | 17 | 209 | 2 | EFO_0010473 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a measurement | 6.33e-03 | 17 | 209 | 2 | EFO_0021969 | |
| Disease | food allergy measurement | 6.33e-03 | 17 | 209 | 2 | EFO_0007016 | |
| Disease | Disease Exacerbation | 6.53e-03 | 165 | 209 | 5 | C0235874 | |
| Disease | alcohol dependence measurement | 7.01e-03 | 55 | 209 | 3 | EFO_0007835 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EGLLDQQQGDVKTGA | 256 | Q14146 | |
| TDQQGGVAEVKGTQL | 96 | P49069 | |
| QGAGLISQAGLKADN | 96 | P0DMU3 | |
| QGQVAEGGVLDASAK | 566 | P11171 | |
| INRDGFGLNQGAEKT | 3796 | Q99996 | |
| VGGNAALIGQKFAAN | 156 | Q9BRR6 | |
| GKAQPAGEELATANQ | 11 | Q9UQB9 | |
| HSSGKQTLNLEEGNG | 771 | Q9NP73 | |
| GNGSANIKLVKNGEN | 91 | Q92870 | |
| LLESGADVNQGKGQD | 186 | Q96DX5 | |
| RNFEALNSKGGGNQV | 966 | Q8TDI0 | |
| CQADVKSGNGQAGVQ | 311 | P29275 | |
| NTQVGLKGAQLSGGQ | 1146 | Q2M3G0 | |
| GKSLNGDVNVNGLST | 46 | Q9UIF9 | |
| QQQVAGGALGATEAQ | 156 | Q7RTS1 | |
| NTNGFIIAKDDGNGS | 1366 | Q8WXG9 | |
| GENGASGKQNSEQID | 1331 | Q68CP9 | |
| GANFKGNTIEIQGDD | 156 | P53674 | |
| NVGSQGSQLSRGEKQ | 1211 | O95342 | |
| LVDQGSQNGTIVNGK | 471 | Q8N302 | |
| GKEENITANGIQGQV | 126 | Q9NZW4 | |
| GNTDKNTQNGDVGDA | 156 | Q9NZW4 | |
| EAGNGKDSSNNSKGQ | 266 | Q9NZW4 | |
| VVGSSGQNGDEKQNI | 346 | P08172 | |
| AGTDGNALQDQQLSK | 1111 | Q8WZ64 | |
| ASQNGAPALVKQEEG | 736 | O14529 | |
| LAGEVTKTIGNNGDQ | 246 | Q9Y394 | |
| VGDKGNSVSANLGDN | 626 | Q12830 | |
| SNGGAIQNQESGIKE | 1921 | Q00975 | |
| GGVGHNQKTGIATVN | 751 | Q9H251 | |
| GKQISRSSGEQQNKG | 511 | Q9UER7 | |
| VGISGNEGLQAANSS | 816 | Q9Y2Q0 | |
| QKDDNGFGLTVSGDN | 76 | Q9NZN5 | |
| AAGIQALGGTNINDA | 341 | Q14624 | |
| EGGNINKSLVTLGNV | 271 | Q96L93 | |
| KVGANGQNAAGPSAD | 526 | Q9HBD1 | |
| NGQGLGQALVQFKNE | 581 | Q9NTZ6 | |
| VKIEGGNGNVATQQN | 71 | O00559 | |
| GFQAQDISGQKNGRG | 1921 | P49792 | |
| ATQALKRNGAQIADG | 256 | P42696 | |
| LQGVGALGQAASDNS | 1191 | P69849 | |
| FGDGDGTVNLKSALQ | 356 | Q8NCC3 | |
| GTSQGKFQGLDLNEE | 3781 | P98160 | |
| KVQSGQTVALVGNSG | 416 | P08183 | |
| LVKEGANINAQSQNG | 116 | Q01484 | |
| AQKGLQVDLQSDGAA | 121 | P33991 | |
| SQSQVIGTEGGKNAS | 166 | Q9ULC0 | |
| KAVGGNEAAAIFNSA | 126 | Q0GE19 | |
| ATQAGSAGGAVNKLV | 566 | Q9Y5I1 | |
| NVGGETENNGVSKES | 146 | Q15058 | |
| LQGVGALGQAASDNS | 1191 | Q5JPE7 | |
| DNSGNGTQEKIAEGA | 96 | Q92813 | |
| GLQEGKSTEQGNHDQ | 81 | Q9UMX2 | |
| GDQLGEAKASGNLGN | 96 | P81274 | |
| AAGVTDGNEVAKAQQ | 31 | Q9BX68 | |
| ANSKGQNGKRGDADQ | 941 | Q6P0N0 | |
| NQELQLTEFGAKGGS | 2876 | Q5T1H1 | |
| GGDAQADEGQARKSQ | 16 | P33992 | |
| KGNGTILKGDTGNNN | 271 | Q6UXI9 | |
| TEGKQLGQAVNTAQG | 596 | Q8IX03 | |
| VAQQTRAKGGGFEQE | 241 | Q96QG7 | |
| SGGNVNEKNDEGVTL | 211 | Q9Y6X6 | |
| GAVNLQGKGDQDQVS | 206 | Q8IYT1 | |
| AQNNAKVAVLGASGG | 21 | P40926 | |
| DQGQRLNNGAGTKEN | 1216 | Q9ULI0 | |
| GGNVVTAAQAKNLID | 301 | P12268 | |
| ATSGQQSGGTIQDVK | 26 | O14990 | |
| GSGNNISKVQGLLEN | 1326 | Q9BY66 | |
| QGLQKVGDSDGSSNL | 341 | Q9UKJ3 | |
| ASGELGNGNIKLSQT | 171 | P12004 | |
| GSGGGQQSVNHLVKE | 316 | Q53EL6 | |
| NKLGATLANGNQSEE | 526 | P50542 | |
| GEGKGQTNEINALVQ | 696 | P51957 | |
| KAGDGNEAIGALIQN | 466 | O75037 | |
| GKGGENIKSINQQSG | 371 | Q96I24 | |
| SGNTKVFSGGNDEQV | 111 | Q96JK2 | |
| QGAQQSLEAAAQKTG | 671 | Q0VF49 | |
| VNGLGQGLIQSAGKD | 1421 | O94854 | |
| FQDGSGLTQIAQGAQ | 181 | Q6ZTU2 | |
| FGIAVKNIGDINQDG | 416 | P23229 | |
| ENLLGKQFQGTDSGE | 781 | P46013 | |
| ANSANGKNGDSAERG | 546 | Q8TE49 | |
| FDLGNGANLIKGSSN | 966 | Q9ULB1 | |
| GQEGLKSKSVQLNGQ | 531 | Q8WWQ2 | |
| NLGDQQSFGIKTAGL | 661 | O00410 | |
| TSGSIDGNNQLVIKG | 246 | P20042 | |
| GNSKAGNGTLENQKG | 246 | O94916 | |
| QAGVAAANTKGDQEQ | 361 | Q86VI3 | |
| GAGNMVNGLANNAEI | 271 | Q9HC58 | |
| DNSGNGQDKIIVGSF | 31 | Q3SYG4 | |
| DGNTGTQTNGLDFQK | 16 | P14859 | |
| GGNVVTAAQAKNLID | 301 | P20839 | |
| GNVQLEAGEDVGQKN | 151 | P23677 | |
| ASLASGNEVGKNLEG | 996 | Q2VWP7 | |
| SRGVNGLINGKANSN | 616 | Q8WX93 | |
| NVTVNGGGNVTEKLD | 746 | O15439 | |
| ANGQENGHVKSNGDL | 26 | P49006 | |
| NSLQQGDVDGAQRLG | 296 | Q7Z6L0 | |
| ATNQAAGQEEKGKAG | 11 | A6NKN8 | |
| ASGDITNQNSLAGGK | 2051 | Q8NFC6 | |
| TNQNSLAGGKNQGKV | 2056 | Q8NFC6 | |
| ESQGGAQGLKQVLQT | 536 | Q9UFP1 | |
| QTLGENIADNGGLKA | 776 | P0DPD8 | |
| QGSAIQVKNDLSGGV | 256 | Q92838 | |
| NQVKNLGFGGGSEEN | 11 | Q7Z7G2 | |
| QFSQILKNIGENEGG | 51 | Q04446 | |
| NHQSGIRGDAKGQVA | 731 | Q8NFZ0 | |
| SQNQATDGREGGKAL | 676 | B1AJZ9 | |
| LDGSQIILKGSGQQA | 231 | Q6AI39 | |
| ENRANGQSKGFALVG | 116 | Q16630 | |
| NGLNGQVDVSLASAA | 516 | Q96AV8 | |
| QKSGELNGDQVSLGT | 221 | Q96C57 | |
| NNAEQLGAFAAGVKQ | 441 | Q96JB2 | |
| QVQALTQEGQGAGSK | 506 | P29317 | |
| ENKVVANGTGTQGQL | 266 | P08236 | |
| EAGTQQSLQAANKSG | 176 | Q587J8 | |
| GLGTGVAQKQNEDVD | 261 | Q9UFF9 | |
| QRQATKDAGAIAGLN | 156 | P17066 | |
| DNQAGTQGQLKVLGA | 46 | Q15486 | |
| EQENQQLKEGAAGAG | 111 | Q4V328 | |
| ILNAGTNTDGFKEQG | 246 | P49327 | |
| KFGQGVDNAAGQAGN | 151 | Q6UWP8 | |
| AEGEQILSGGVFNKQ | 86 | P30260 | |
| LLGFEANGANGSKAV | 336 | Q7Z5L9 | |
| GKASVNRGAQENGTG | 351 | P28906 | |
| KQQIENGSGAEDNGD | 161 | Q99496 | |
| LGGDNGETKFKGNNQ | 911 | Q15648 | |
| VGTEGGTNLAANNAN | 471 | Q8IXS8 | |
| QKDQHAGARQAGSVG | 181 | Q9BTE3 | |
| QECGSSKEGGNQNKV | 701 | O94851 | |
| NGSALVLQVDSGANA | 841 | P98161 | |
| FQAQDISGQKNGRGV | 931 | P0DJD0 | |
| NGVFKEVEGQSQGSV | 501 | Q9GZY0 | |
| VKIQLQEQGTDGGAF | 586 | Q6ZVC0 | |
| AAAGAQASQAQLGEA | 276 | Q9Y261 | |
| AANVAKGAIQGGLDT | 726 | Q96Q06 | |
| AREVGQGNGLQKAQA | 406 | Q9Y4G2 | |
| GQSAQGAKDQAAEGI | 311 | P82650 | |
| ASHQQNGDAGGDAKV | 51 | Q8IZ73 | |
| GFQAQDISGQKNGRG | 946 | Q7Z3J3 | |
| QKQQEIAAAAATGGS | 261 | Q7L4I2 | |
| AQLNLGNNFKISGGS | 201 | Q8N4H0 | |
| TSVAGQQQGQDGVKV | 556 | Q02446 | |
| NGDNSTGLQVSEKGA | 2196 | Q8WUY3 | |
| VGDEQGRNKCVGNSQ | 536 | P08582 | |
| GVGNVRVKFGQNDAD | 791 | Q8N3T6 | |
| VAAQGGINAALGNME | 101 | P31040 | |
| NDDGGGSAAQKQKIS | 821 | O60282 | |
| ANELNGIVGGKNTVV | 426 | Q969Y0 | |
| DTGFQAQDISGQKNG | 936 | P0DJD1 | |
| AQDISGQKNGRGVIF | 941 | P0DJD1 | |
| QDKSGGRQQFASLVG | 421 | Q96RN1 | |
| KQDVVNAINLDGGGS | 276 | Q9UK23 | |
| SEQQQSKQIGGGKAQ | 2826 | Q9Y520 | |
| VRGATVEGQNGSKSN | 116 | Q9H0F6 | |
| LAQVGAKGDTANEIG | 41 | P36952 | |
| GVKGLTAVSNNAGVD | 81 | P55809 | |
| SGGSLQAGQQKEGEQ | 376 | P08047 | |
| TAAELLQSQGSQAGG | 401 | Q14141 | |
| LQSQGSQAGGSQTLK | 406 | Q14141 | |
| ESLGGSESSGQQNQK | 306 | Q96KW2 | |
| QGSAKNGENTANGEE | 121 | Q9BZK7 | |
| GVNASAQKFATDGEG | 586 | Q01082 | |
| GSVKRVSENNGNGKN | 1851 | Q13023 | |
| DSFGVQIKGANDQGA | 76 | Q9P2M7 | |
| QIKGANDQGASGALS | 81 | Q9P2M7 | |
| LGIDAAQKNLSGGQG | 226 | Q96F83 | |
| NNGLIDAFGALTSGN | 466 | Q14CN2 | |
| SLDSGNQNGGNDDKT | 386 | Q9NQ89 | |
| QISGKGEDQGSFNAD | 486 | P48736 | |
| EQTGSKTLNGGSDAQ | 471 | O75475 | |
| GTGKKAVAGQQQASV | 271 | Q15025 | |
| GREEAGAEKIFQNNG | 166 | Q8IWX7 | |
| KGGVNDNFQGVLQNV | 201 | P07996 | |
| LNLQTENKGSVVSGG | 121 | O00308 | |
| GSNSNGERKDLQLSG | 431 | Q9H0M4 | |
| NSVAAAANGLGAEKD | 111 | Q9H7S9 | |
| KAEGAQNQGQKGEGA | 501 | Q9P2E9 | |
| SGAGLVQINKSNGKE | 86 | P20645 | |
| GDGSRENGNNSSDKV | 171 | Q9UMS5 | |
| NLLQAAGNVGQASGE | 636 | Q9Y490 | |
| GNGAVAAAAAAQDTQ | 41 | Q02447 | |
| DQGAGGNGNVLKELS | 516 | O15067 | |
| NENSEGTGVALGRNQ | 16 | Q8WUN7 | |
| KDQAFGNGNGIIIIA | 236 | O00442 | |
| GQQVSGAGAAQNLDL | 226 | Q86SX3 | |
| KIGDVVGSSGANQQT | 376 | Q9Y263 | |
| ILENQGGKGQNTLSS | 161 | Q9HBJ7 | |
| GGKGQNTLSSDVQTN | 166 | Q9HBJ7 | |
| VNFVVGNNGSGKSAV | 71 | Q96SB8 | |
| GQVDDAGKALGVISN | 396 | O94876 | |
| GKLGGFTQENNTIDS | 371 | Q9P273 | |
| AKKAEADGSGQQNVG | 336 | P78364 | |
| DEQNEASKTNGLGAA | 756 | Q9Y2I9 | |
| GSQSGAAKDGTANLQ | 471 | Q6AHZ1 | |
| AKNGQVIGIGAGQQS | 436 | P31939 | |
| SEENQNAKVGSGAIQ | 1126 | O43151 | |
| KGNNQAEAGGDAEVL | 146 | Q1RN00 | |
| GQDSGSQAQGLKAAV | 201 | Q9ULM0 | |
| LAKQAASGLVGQENA | 31 | Q9Y265 | |
| AGALVQNTEKGPNAE | 471 | Q9UPN7 | |
| NKLNANQGGFENGEI | 261 | Q6IQ21 | |
| SKGAIVDQLGGDLNS | 111 | Q8IUH5 | |
| EAGANVDAQNIKGES | 246 | Q8IUH5 | |
| GLLGQAEKTQGQGTA | 1956 | Q96JG9 | |
| SKGAGNNVLVIDGQQ | 476 | Q9UBW7 | |
| GSQKNKGGNNLLVIS | 986 | Q17R98 | |
| DAGKAVTLQQGFNQG | 51 | Q9NRH1 | |
| KSAQGTGFELGQLQS | 431 | Q9C0B5 | |
| TEIQGDGCSGHKNQN | 71 | A6NK53 | |
| ATQREGNSGGKIQTE | 71 | Q12901 | |
| GNQGNSKGRVAQNKT | 276 | Q8TF39 | |
| VTKGDQGDQNDLENG | 1751 | Q9UI33 | |
| KDISETLGNNGVGFQ | 276 | Q9BXG8 | |
| AQGQGQRSSKAEGAQ | 821 | Q8NEE8 | |
| GNKAAIQGNGDVGAA | 161 | O94901 | |
| KAGGQEQNGTQQSIV | 671 | Q92889 | |
| IGSGASSKAQQLLQG | 431 | Q14669 | |
| SGFVKALGLDTGQQQ | 166 | Q86UV5 | |
| LADAKGLQDTGGTVN | 261 | Q96RL1 | |
| QGGKDFTGDSDLQQQ | 151 | P17021 | |
| ATQREGNSGGKIQTE | 71 | Q2VY69 | |
| SKEGNGIGVNSSNRL | 336 | P24723 | |
| TGGGADQTLLQKLQA | 471 | O00160 | |
| VAAGADVNAQEQKSG | 671 | P19838 |